CN103330837A - Traditional Chinese medicine composition for curing osteoporosis of menopausal women - Google Patents
Traditional Chinese medicine composition for curing osteoporosis of menopausal women Download PDFInfo
- Publication number
- CN103330837A CN103330837A CN2013102995626A CN201310299562A CN103330837A CN 103330837 A CN103330837 A CN 103330837A CN 2013102995626 A CN2013102995626 A CN 2013102995626A CN 201310299562 A CN201310299562 A CN 201310299562A CN 103330837 A CN103330837 A CN 103330837A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- fructus
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 162
- 208000001132 Osteoporosis Diseases 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 claims abstract description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 63
- 229940079593 drug Drugs 0.000 claims description 51
- 239000000284 extract Substances 0.000 claims description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 239000006187 pill Substances 0.000 claims description 15
- 239000011347 resin Substances 0.000 claims description 15
- 229920005989 resin Polymers 0.000 claims description 15
- 239000002552 dosage form Substances 0.000 claims description 14
- 210000000582 semen Anatomy 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 13
- 238000000605 extraction Methods 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 11
- 241000190633 Cordyceps Species 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000003826 tablet Substances 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 235000008504 concentrate Nutrition 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 238000007670 refining Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- -1 sublimed preparation Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 239000008298 dragée Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 241001312741 Gekko swinhonis Species 0.000 claims 3
- 241000195947 Lycopodium Species 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000006837 decompression Effects 0.000 claims 2
- 238000010828 elution Methods 0.000 claims 2
- 238000004064 recycling Methods 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 claims 1
- 230000000274 adsorptive effect Effects 0.000 claims 1
- 235000011837 pasties Nutrition 0.000 claims 1
- 239000011505 plaster Substances 0.000 claims 1
- 230000008719 thickening Effects 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 70
- 230000000694 effects Effects 0.000 abstract description 43
- 210000000988 bone and bone Anatomy 0.000 abstract description 40
- 210000004185 liver Anatomy 0.000 abstract description 31
- 238000005728 strengthening Methods 0.000 abstract description 19
- 201000010099 disease Diseases 0.000 abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 210000002435 tendon Anatomy 0.000 abstract description 8
- 208000001685 postmenopausal osteoporosis Diseases 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 3
- 230000007721 medicinal effect Effects 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 231100001231 less toxic Toxicity 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 34
- 230000006870 function Effects 0.000 description 34
- 210000004369 blood Anatomy 0.000 description 33
- 239000008280 blood Substances 0.000 description 33
- 210000000952 spleen Anatomy 0.000 description 31
- 239000000796 flavoring agent Substances 0.000 description 26
- 235000019634 flavors Nutrition 0.000 description 26
- 235000008708 Morus alba Nutrition 0.000 description 24
- 240000000249 Morus alba Species 0.000 description 23
- 235000013336 milk Nutrition 0.000 description 23
- 210000004080 milk Anatomy 0.000 description 23
- 239000008267 milk Substances 0.000 description 23
- 230000007812 deficiency Effects 0.000 description 22
- 208000006820 Arthralgia Diseases 0.000 description 21
- 230000001737 promoting effect Effects 0.000 description 21
- 239000002994 raw material Substances 0.000 description 19
- 241000893536 Epimedium Species 0.000 description 18
- 240000002853 Nelumbo nucifera Species 0.000 description 18
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 18
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 18
- 235000018905 epimedium Nutrition 0.000 description 18
- 210000003205 muscle Anatomy 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 16
- 235000009508 confectionery Nutrition 0.000 description 16
- 210000004072 lung Anatomy 0.000 description 14
- 206010011224 Cough Diseases 0.000 description 13
- 210000001624 hip Anatomy 0.000 description 13
- 244000132619 red sage Species 0.000 description 13
- 235000003434 Sesamum indicum Nutrition 0.000 description 12
- 201000001881 impotence Diseases 0.000 description 12
- 239000002398 materia medica Substances 0.000 description 12
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 11
- 241000270666 Testudines Species 0.000 description 11
- 238000009826 distribution Methods 0.000 description 11
- 241000271309 Aquilaria crassna Species 0.000 description 10
- 241000234276 Curculigo Species 0.000 description 10
- 235000019013 Viburnum opulus Nutrition 0.000 description 10
- 210000001015 abdomen Anatomy 0.000 description 10
- 230000037182 bone density Effects 0.000 description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 description 10
- 239000011707 mineral Substances 0.000 description 10
- 210000000056 organ Anatomy 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 244000144730 Amygdalus persica Species 0.000 description 9
- 235000009467 Carica papaya Nutrition 0.000 description 9
- 240000006432 Carica papaya Species 0.000 description 9
- 241001070941 Castanea Species 0.000 description 9
- 235000014036 Castanea Nutrition 0.000 description 9
- 244000205754 Colocasia esculenta Species 0.000 description 9
- 235000006481 Colocasia esculenta Nutrition 0.000 description 9
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 9
- 241000096284 Gynochthodes officinalis Species 0.000 description 9
- 235000006040 Prunus persica var persica Nutrition 0.000 description 9
- 240000007651 Rubus glaucus Species 0.000 description 9
- 235000011034 Rubus glaucus Nutrition 0.000 description 9
- 235000009122 Rubus idaeus Nutrition 0.000 description 9
- 241000207961 Sesamum Species 0.000 description 9
- 244000071378 Viburnum opulus Species 0.000 description 9
- 240000008866 Ziziphus nummularia Species 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 208000034783 hypoesthesia Diseases 0.000 description 9
- 230000027939 micturition Effects 0.000 description 9
- 238000010792 warming Methods 0.000 description 9
- 208000004998 Abdominal Pain Diseases 0.000 description 8
- 240000007371 Cuscuta campestris Species 0.000 description 8
- 241000735234 Ligustrum Species 0.000 description 8
- 240000002624 Mespilus germanica Species 0.000 description 8
- 235000017784 Mespilus germanica Nutrition 0.000 description 8
- 235000000560 Mimusops elengi Nutrition 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 8
- 208000025747 Rheumatic disease Diseases 0.000 description 8
- 235000007837 Vangueria infausta Nutrition 0.000 description 8
- 210000003127 knee Anatomy 0.000 description 8
- 201000004792 malaria Diseases 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 231100000862 numbness Toxicity 0.000 description 8
- 241000758794 Asarum Species 0.000 description 7
- 206010017076 Fracture Diseases 0.000 description 7
- 230000002159 abnormal effect Effects 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- 230000000552 rheumatic effect Effects 0.000 description 7
- 206010039073 rheumatoid arthritis Diseases 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 244000025254 Cannabis sativa Species 0.000 description 6
- 241000195955 Equisetum hyemale Species 0.000 description 6
- 244000061508 Eriobotrya japonica Species 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 208000037093 Menstruation Disturbances Diseases 0.000 description 6
- 206010027339 Menstruation irregular Diseases 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 241000207929 Scutellaria Species 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000037406 food intake Effects 0.000 description 6
- 235000012631 food intake Nutrition 0.000 description 6
- 210000004705 lumbosacral region Anatomy 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 208000008035 Back Pain Diseases 0.000 description 5
- 206010006002 Bone pain Diseases 0.000 description 5
- 241001327300 Cymbopogon schoenanthus Species 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 208000004044 Hypesthesia Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 238000009547 dual-energy X-ray absorptiometry Methods 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010000060 Abdominal distension Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 208000034656 Contusions Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 241000208152 Geranium Species 0.000 description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 206010059013 Nocturnal emission Diseases 0.000 description 4
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 4
- 206010033799 Paralysis Diseases 0.000 description 4
- 206010038743 Restlessness Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 4
- 238000011047 acute toxicity test Methods 0.000 description 4
- 208000034158 bleeding Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 210000002436 femur neck Anatomy 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 210000001503 joint Anatomy 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- 208000031648 Body Weight Changes Diseases 0.000 description 3
- 206010065687 Bone loss Diseases 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 208000008967 Enuresis Diseases 0.000 description 3
- 241001092070 Eriobotrya Species 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 206010023232 Joint swelling Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 244000241838 Lycium barbarum Species 0.000 description 3
- 235000015459 Lycium barbarum Nutrition 0.000 description 3
- 235000015468 Lycium chinense Nutrition 0.000 description 3
- 208000000112 Myalgia Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 240000007164 Salvia officinalis Species 0.000 description 3
- 244000000231 Sesamum indicum Species 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000031975 Yang Deficiency Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 230000003542 behavioural effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000004579 body weight change Effects 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 201000000916 idiopathic juvenile osteoporosis Diseases 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 231100001252 long-term toxicity Toxicity 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 208000013465 muscle pain Diseases 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000001995 reticulocyte Anatomy 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 208000004371 toothache Diseases 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 241000173529 Aconitum napellus Species 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 208000002881 Colic Diseases 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000158403 Phalaenopsis japonica Species 0.000 description 2
- 206010034944 Photokeratitis Diseases 0.000 description 2
- 235000017276 Salvia Nutrition 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229940023019 aconite Drugs 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000007791 dehumidification Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 208000024765 knee pain Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 238000010181 skin prick test Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 206010003671 Atrioventricular Block Diseases 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 206010068975 Bone atrophy Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241001633683 Centipeda <firmicute> Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 208000013017 Child Nutrition disease Diseases 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 241000218158 Clematis Species 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 240000006766 Cornus mas Species 0.000 description 1
- 241000207901 Cuscuta Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 241000218671 Ephedra Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000025599 Heat Stress disease Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 description 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010072970 Meniscus injury Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000157491 Morinda Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000035175 Oligomenorrhea Diseases 0.000 description 1
- 206010030295 Oligomenorrhoea Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 208000003142 Retained Placenta Diseases 0.000 description 1
- 206010038758 Retained placenta or membranes Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- 208000020221 Short stature Diseases 0.000 description 1
- 206010040639 Sick sinus syndrome Diseases 0.000 description 1
- 208000033041 Somatoform disorder gastrointestinal Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010058907 Spinal deformity Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 201000002661 Spondylitis Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046940 Vaginal prolapse Diseases 0.000 description 1
- 241000208832 Viburnum Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010069055 Vulvovaginal pain Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241001506766 Xanthium Species 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 208000024753 bloody sputum Diseases 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000008669 duhuo Substances 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 208000010515 dystocia Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000009760 functional impairment Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 1
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 208000037805 labour Diseases 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 231100000861 limb weakness Toxicity 0.000 description 1
- 208000027905 limb weakness Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000017524 noni Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000018052 penile erection Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000010341 ping gan Substances 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000021148 salty food Nutrition 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 230000007371 visceral function Effects 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明所要解决的技术问题在于,提供了一种治疗绝经妇女骨质疏松症的中药组合物,配方简单、制作工艺简便,毒副作用小且给药方便,药剂易于制造,成本低廉的新药。本发明的中药组合物,配伍复合中医理论,各药物功效产生协同作用,使之具有益肝补肾,强筋固骨的功效,从而能够有效治疗绝经后骨质疏松症。本发明采用不同药性的中药材,进行了科学配伍,能达到理想的治疗效果,且安全,毒副作用小,制备简单,能直达病因,治愈时间短,防治见效快。The technical problem to be solved by the present invention is to provide a traditional Chinese medicine composition for treating postmenopausal women's osteoporosis, which has simple formula, simple manufacturing process, less toxic and side effects, convenient administration, easy preparation of medicament, and low cost. The traditional Chinese medicine composition of the present invention is compatible with the theory of traditional Chinese medicine, and the efficacy of each medicine produces a synergistic effect, so that it has the effects of nourishing the liver and kidney, strengthening tendons and strengthening bones, thereby effectively treating postmenopausal osteoporosis. The invention adopts traditional Chinese medicinal materials with different medicinal properties, carries out scientific compatibility, can achieve an ideal therapeutic effect, is safe, has little toxic and side effects, is simple to prepare, can directly reach the cause of the disease, has short healing time and quick prevention and treatment effect.
Description
技术领域 technical field
本发明涉及中药领域,具体地说是一种治疗绝经妇女骨质疏松症的中药组合物。 The present invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating postmenopausal women with osteoporosis. the
背景技术 Background technique
骨质疏松症 (osteoporosis) 是一种以骨量减少,骨的微细结构破坏为特征,致骨的脆性增加,易于骨折的一种全身性骨病。骨质疏松症可分为三大类:原发性骨质疏松症、继发性骨质疏松症和特发性骨质疏松症。 Osteoporosis is a systemic bone disease characterized by decreased bone mass and destruction of bone microstructure, resulting in increased bone fragility and easy fractures. Osteoporosis can be divided into three major categories: primary osteoporosis, secondary osteoporosis, and idiopathic osteoporosis. the
第一类原发性骨质疏松症又可分为绝经妇女的骨质疏松症(I 型)和老年性骨质疏松症 (II 型); The first type of primary osteoporosis can be further divided into postmenopausal osteoporosis (type I) and senile osteoporosis (type II);
第二类为继发性骨质疏松症,它是由其他疾病(如肾衰竭,过量甲状腺荷尔蒙或白血病),或药物(如类固醇)等一些因素所诱发的骨质疏松症 ; The second category is secondary osteoporosis, which is osteoporosis induced by other diseases (such as kidney failure, excess thyroid hormone or leukemia), or drugs (such as steroids);
第三类为特发性骨质疏松症,多见于 8~14 岁的青少年或成人,多半有遗传家庭史,女性多于男性,妇女妊娠及哺乳期所发生的骨质疏松也可列入特发性骨质疏松。 The third category is idiopathic osteoporosis, which is more common in adolescents or adults aged 8 to 14. Most of them have a genetic family history, and women are more than men. Osteoporosis that occurs during pregnancy and lactation can also be included in idiopathic osteoporosis. Osteoporosis.
现代医学认为绝经后骨质疏松症(postmenopausal osteoporosis,POP)是指绝经后妇女由于卵巢功能减退,雌激素下降,导致体内骨量减少及骨组织结构变化为特征的,临床表现为骨脆性和骨折易感性增加的一种代谢性疾病。 Modern medicine believes that postmenopausal osteoporosis (postmenopausal osteoporosis, POP) refers to the decline of ovarian function and estrogen in postmenopausal women, which is characterized by bone loss and changes in bone tissue structure in the body. The clinical manifestations are bone fragility and fractures. A metabolic disorder in which susceptibility is increased. the
骨质疏松症是绝经后妇女的一种常见病,多发病,危害日益严重,被称为“无声无息的流行病”,已经引起全世界的关注。临床病症表现在 :最早背疼,随之椎体压缩,还可伴有脊柱畸形,驼背变矮等,严重者可引起胸廓畸形,影响肺功 Osteoporosis is a common disease in postmenopausal women. It is a frequently occurring disease and its harm is becoming more and more serious. It is called a "silent epidemic" and has attracted worldwide attention. The clinical manifestations are as follows: back pain at the earliest, followed by vertebral body compression, accompanied by spinal deformity, hunchback becoming shorter, etc., severe cases can cause thoracic deformity and affect lung function
能,并发骨折,并且随着年龄的增加,骨折的危险性增加。目前对此症西医治疗方法多采用补充雌激素、钙剂和维生素,但长期大量服用雌激素有可能引发子宫内膜癌和乳房癌等副作用,且钙剂和维生素的补充在剂量上又难以控制,而中医药在绝经后骨质疏松症的药物治疗方面取得了不少成果。 Yes, concurrent fractures, and the risk of fractures increases with age. At present, Western medicine treatment methods for this disease mostly use estrogen supplementation, calcium and vitamins, but long-term use of large amounts of estrogen may cause side effects such as endometrial cancer and breast cancer, and the supplementation of calcium and vitamins is difficult to control in terms of dosage. , and traditional Chinese medicine has made many achievements in the drug treatment of postmenopausal osteoporosis.
中国传统中医学虽无绝经后骨质疏松症的症名,但其临床表现、发病机制应归属于“虚劳”、“骨痿、“骨痹”、“骨枯”的范畴。 Although traditional Chinese medicine does not have a name for postmenopausal osteoporosis, its clinical manifestations and pathogenesis should belong to the categories of "asthenia", "bone atrophy", "gubi" and "bone dryness".
中医认为肾虚是骨质疏松症的主要病因,在临床根据阴阳盛衰不同可分阴虚、阳虚 ;常兼夹多脏腑虚损、血瘀、气滞、寒湿症等。临床治疗以“肾藏精主骨生髓”为理,以“补肾”为法。 Traditional Chinese medicine believes that kidney deficiency is the main cause of osteoporosis. Clinically, it can be divided into yin deficiency and yang deficiency according to the rise and fall of yin and yang; The clinical treatment is based on the principle of "kidney storing essence governs the production of bone marrow" and "tonifying the kidney" as the method. the
发明内容 Contents of the invention
本发明所要解决的技术问题在于,提供了一种配方简单、制作工艺简便,毒副作用小且给药方便,药剂易于制造,成本低廉的新药。本发明的中药组合物,配伍复合中医理论,各药物功效产生协同作用,使之具有益肝补肾,强筋固骨的功效,从而能够有效治疗绝经后骨质疏松症。本发明采用不同药性的中药材,进行了科学配伍,能达到理想的治疗效果,且安全,毒副作用小,制备简单,能直达病因,治愈时间短,防治见效快。 The technical problem to be solved by the present invention is to provide a new drug with simple formula, simple manufacturing process, less toxic and side effects, convenient administration, easy manufacture of medicament, and low cost. The traditional Chinese medicine composition of the present invention is compatible with the theory of traditional Chinese medicine, and the efficacy of each medicine produces a synergistic effect, so that it has the effects of nourishing the liver and kidney, strengthening tendons and strengthening bones, thereby effectively treating postmenopausal osteoporosis. The invention adopts traditional Chinese medicinal materials with different medicinal properties, carries out scientific compatibility, can achieve an ideal therapeutic effect, is safe, has little toxic and side effects, is simple to prepare, can directly reach the cause of the disease, has short healing time and quick prevention and treatment effect. the
为解决上述技术问题,本发明提供一种治疗绝经妇女骨质疏松症的中药组合物,所述中药组合物中各种原料药的重量份数比为: In order to solve the above-mentioned technical problems, the invention provides a kind of Chinese medicine composition for the treatment of postmenopausal women's osteoporosis, the weight-number ratio of various crude drugs in the said Chinese medicine composition is:
枇杷芋1-10份、覆盆子1-10份、菟丝子5-15份、栗子1-5份、枸杞子5-15份、女贞子0.5-0.9份、黄精1-15份、淫羊藿1-15份、雪莲花0.1-0.8份、巴戟天0.01-0.09份、仙茅0.01-0.09份、老鹳草0.01-0.09份、乌药叶1-15份、沉香1-10份、路路通1-15份、壁虎1-5份、鳖甲1-15份、豨莶草0.01-0.09份、丹参1-15份、芝麻1-10份、一叶萩0.01-0.09份、仙灵脾0.01-0.09份、马尾千金草1-10份、心叶荚蒾根1-10份、双股箭0.01-0.09份、桃仁1-15份、大枣1-15份、桑寄生1-5份、桑椹10-15份、蜂乳10-15份、冬虫夏草1-5份、木瓜1-15份。 1-10 parts of loquat taro, 1-10 parts of raspberry, 5-15 parts of dodder, 1-5 parts of chestnut, 5-15 parts of medlar, 0.5-0.9 part of privet fruit, 1-15 parts of sealwort, epimedium 1-15 parts, 0.1-0.8 parts of snow lotus, 0.01-0.09 parts of Morinda officinalis, 0.01-0.09 parts of curculigo, 0.01-0.09 parts of geranium, 1-15 parts of black medicine leaves, 1-10 parts of agarwood, road 1-15 parts of Lutong, 1-5 parts of Gecko, 1-15 parts of Turtle Shell, 0.01-0.09 parts of Siberia chinensis, 1-15 parts of Salvia miltiorrhiza, 1-10 parts of sesame, 0.01-0.09 parts of Hagi chinensis, fairy 0.01-0.09 servings of spleen, 1-10 servings of Phalaenopsis japonica, 1-10 servings of viburnum root, 0.01-0.09 servings of double-strand arrow, 1-15 servings of peach kernel, 1-15 servings of jujube, 1-5 servings of mulberry 10-15 parts of mulberry, 10-15 parts of bee milk, 1-5 parts of Cordyceps sinensis, 1-15 parts of papaya.
本发明提供一种治疗绝经妇女骨质疏松症的中药组合物,所述中药组合物中各种原料药的重量份数比为: The present invention provides a kind of Chinese medicine composition for treating postmenopausal women's osteoporosis, the weight-number ratio of various raw materials in the said Chinese medicine composition is:
枇杷芋2-8份、覆盆子2-8份、菟丝子6-14份、栗子2-4份、枸杞子6-14份、女贞子0.6-0.8份、黄精2-14份、淫羊藿2-14份、雪莲花0.2-0.7份、巴戟天0.02-0.08份、仙茅0.02-0.08份、老鹳草0.02-0.08份、乌药叶2-14份、沉香2-9份、路路通2-14份、壁虎2-4份、鳖甲2-14份、豨莶草0.02-0.08份、丹参2-14份、芝麻2-8份、一叶萩0.02-0.08份、仙灵脾0.02-0.08份、马尾千金草2-8份、心叶荚蒾根2-8份、双股箭0.02-0.08份、桃仁2-14份、大枣2-14份、桑寄生2-4份、桑椹11-14份、蜂乳11-14份、冬虫夏草2-4份、木瓜2-14份。 2-8 parts of loquat taro, 2-8 parts of raspberry, 6-14 parts of dodder, 2-4 parts of chestnut, 6-14 parts of medlar, 0.6-0.8 part of privet fruit, 2-14 parts of sealwort, epimedium 2-14 parts, 0.2-0.7 parts of snow lotus, 0.02-0.08 parts of Morinda officinalis, 0.02-0.08 parts of curculigo, 0.02-0.08 parts of geranium, 2-14 parts of black medicine leaves, 2-9 parts of agarwood, road 2-14 servings of Lutong, 2-4 servings of Gecko, 2-14 servings of Turtle Shell, 0.02-0.08 servings of Scutellaria, 2-14 servings of Salvia, 2-8 servings of Sesame, 0.02-0.08 servings of Hagi, Faerie 0.02-0.08 servings of spleen, 2-8 servings of Phalaenopsis japonica, 2-8 servings of viburnum root, 0.02-0.08 servings of double-strand arrow, 2-14 servings of peach kernel, 2-14 servings of jujube, 2-4 servings of mulberry 11-14 parts of mulberry, 11-14 parts of bee milk, 2-4 parts of Cordyceps sinensis, 2-14 parts of papaya.
本发明提供一种治疗绝经妇女骨质疏松症的中药组合物,所述中药组合物中各种原料药的重量份数比为: The present invention provides a kind of Chinese medicine composition for treating postmenopausal women's osteoporosis, the weight-number ratio of various raw materials in the said Chinese medicine composition is:
枇杷芋5份、覆盆子5份、菟丝子10份、栗子3份、枸杞子10份、女贞子0.7份、黄精10份、淫羊藿10份、雪莲花0.5份、巴戟天0.05份、仙茅0.05份、老鹳草0.05份、乌药叶10份、沉香8份、路路通10份、壁虎3份、鳖甲10份、豨莶草0.05份、丹参12份、芝麻5份、一叶萩0.05份、仙灵脾0.05份、马尾千金草5份、心叶荚蒾根5份、双股箭0.05份、桃仁12份、大枣12份、桑寄生3份、桑椹12份、蜂乳12份、冬虫夏草3份、木瓜10份。 5 parts of loquat taro, 5 parts of raspberry, 10 parts of dodder, 3 parts of chestnut, 10 parts of medlar, 0.7 part of Ligustrum lucidum, 10 parts of sealwort, 10 parts of epimedium, 0.5 part of snow lotus, 0.05 part of Morinda officinalis, 0.05 parts curculigo, 0.05 parts geranium, 10 parts cicatrix, 8 parts agarwood, 10 parts passepartout, 3 parts gecko, 10 parts turtle shell, 0.05 parts scallop grass, 12 parts salvia, 5 parts sesame, 0.05 parts of hagi, 0.05 parts of celestial spirit spleen, 5 parts of centipeda, 5 parts of viburnum root, 0.05 parts of double-strand arrow, 12 parts of peach kernel, 12 parts of jujube, 3 parts of mulberry, 12 parts of mulberry, 12 parts of bee milk, 3 parts of Cordyceps sinensis, 10 parts of papaya.
为解决上述技术问题,本发明还提供一种治疗绝经妇女骨质疏松症的中药组合物的制备方法,所述中药组合物的剂型为蜜炼丸剂的制备方法包括: In order to solve the above-mentioned technical problems, the present invention also provides a preparation method of a Chinese medicine composition for the treatment of postmenopausal women's osteoporosis, the dosage form of the Chinese medicine composition is honey refining pills. The preparation method comprises:
a、将除蜂乳外的原料药放入乙醇浸泡,热提取1次,成浸膏状,为组分1; a. Soak the raw materials except bee milk in ethanol, and heat extract once to form an extract, which is component 1;
b、药渣加水提取2次,浓缩过滤为浸膏状,为组分2; b. The dregs are extracted twice with water, concentrated and filtered to obtain an extract, which is component 2;
c、将上述两种浸膏浓缩成糊状,加蜂乳搓成丸剂。 c. Concentrate the above two extracts into a paste, add bee milk and knead into a pill.
所述步骤a中,将除蜂乳外的原料药加入5-10倍量的60-90%乙醇浸泡1-2小时,加热提取1-2小时,去上清液,药糊继续加热浓缩至浸膏状,静置备用,成为组分1。 In the step a, add 5-10 times the amount of 60-90% ethanol to the raw material medicine except bee milk, soak for 1-2 hours, heat and extract for 1-2 hours, remove the supernatant, continue heating and concentrating the medicine paste to In the form of extract, stand for later use and become component 1. the
所述步骤b中,可以将药渣加水浸泡1-2小时,提取两次,每次1-1.5小时,合并提取液, 80-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时 1.36的浸膏,加热浓缩,30分钟~45分钟,提取活性成份,将浓缩液静置成浸膏状,作为组分2。 In the step b, the dregs can be soaked in water for 1-2 hours, extracted twice, each time for 1-1.5 hours, and the extracts are combined, filtered at 80-120 mesh, and then ultrafiltered with a cut-off molecular weight of 5000-10000 Column ultrafiltration, the ultrafiltrate is concentrated under reduced pressure and the extract with a relative density of 1.36 at 80°C is heated and concentrated for 30 minutes to 45 minutes to extract the active ingredient, and the concentrated solution is left to stand to form an extract, which is used as component 2. the
为解决上述技术问题,本发明也提供一种治疗绝经妇女骨质疏松症的中药组合物的制备方法,所述中药组合物的剂型为胶囊剂的制备方法包括: In order to solve the problems of the technologies described above, the present invention also provides a method for preparing a Chinese medicine composition for the treatment of postmenopausal women's osteoporosis. The dosage form of the Chinese medicine composition is a capsule. The preparation method comprises:
a、将丹参放入乙醇中加热回流提取; a, putting Salvia miltiorrhiza into ethanol and heating under reflux to extract;
b、再取上述方中的剩余原料除鳖甲外,加水加热回流提取; b. Take the remaining raw materials in the above recipe except turtle shells, add water and heat under reflux to extract;
c、将上述两种提取液合并,减压回收乙醇并浓缩抽滤吸附,得到原料药;加入磨成细粉的鳖甲,罐装。 c. Combine the above two extracts, recover the ethanol under reduced pressure, concentrate and suction, filter and absorb to obtain the raw material drug; add the turtle shells ground into fine powder, and pack in cans.
所述步骤a中,可以将丹参放入10倍量乙醇中,加热回流提取2次,每次1~2小时,提取活性成份,将2次提取液合并静置; In the step a, put Salvia miltiorrhiza into 10 times the amount of ethanol, heat and reflux for extraction twice, each time for 1-2 hours, extract the active ingredient, combine the two extracts and let stand;
所述步骤b中,将剩余原料除鳖甲外放入10倍量水中,加热回流提取3次,每次45分钟~1小时,将3次提取液合并静置。 In the step b, the remaining raw materials except turtle shells are put into 10 times the amount of water, heated and refluxed for 3 extractions, each time for 45 minutes to 1 hour, and the 3 extracts are combined and allowed to stand.
所述步骤c中, 可以将上述两种滤液的合并,减压回收乙醇并浓缩至药液浓度为0.4g生药/mL,抽滤后,滤液的相对密度约为20℃时1.06;上述滤液经体积为10L的大孔吸附树脂柱,先用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除溶剂,得到原料药粉;再将鳖甲磨成细粉,与得到的原料药粉一起装入胶囊。 In the step c, the above two filtrates can be combined, and the ethanol can be recovered under reduced pressure and concentrated to a concentration of 0.4g crude drug/mL. After suction filtration, the relative density of the filtrate is about 1.06 at 20°C; A macroporous adsorption resin column with a volume of 10 L is first eluted with deionized water or distilled water of 10 times the volume of the resin column, and then eluted with 95% ethanol of 5 times the volume of the resin column, and the ethanol eluate is collected, and the solvent is removed to obtain Raw material medicine powder; then the turtle shell is ground into fine powder, and packed into capsules together with the obtained raw material medicine powder. the
为解决上述技术问题,本发明也提供一种治疗绝经妇女骨质疏松症的中药组合物的制备方法,所述中药组合物的剂型为片剂的制备方法包括: In order to solve the problems of the technologies described above, the present invention also provides a method for preparing a Chinese medicine composition for the treatment of postmenopausal women's osteoporosis, wherein the dosage form of the Chinese medicine composition is a tablet and the preparation method comprises:
将丹参放入10倍量乙醇中,加热回流提取2次,每次1~2小时,提取活性成份,将2次提取液合并静置;再取上述方中的剩余原料放入10倍量水中,加热回流提取3次,每次30分钟~1小时,将3次提取液合并静置;将上述两种提取液合并,减压回收乙醇并浓缩至药液浓度为0.5g生药/mL,抽滤后,滤液的相对密度约为1.08(20℃);上述滤液经体积为10L的大孔吸附树脂柱,先用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除溶剂,得到原料药;加入淀粉或糊精压片。 Put Salvia miltiorrhiza into 10 times the amount of ethanol, heat and reflux for extraction twice, each time for 1 to 2 hours, extract the active ingredients, combine the two extractions and let stand; then take the remaining raw materials in the above recipe and put them into 10 times the amount of water , heated and refluxed for 3 times, each time for 30 minutes to 1 hour, the three extracts were combined and left standing; the above two extracts were combined, ethanol was recovered under reduced pressure and concentrated until the concentration of the drug solution was 0.5g crude drug/mL, pumped After filtration, the relative density of the filtrate is about 1.08 (20°C); the above-mentioned filtrate passes through a macroporous adsorption resin column with a volume of 10L, and is first eluted with deionized water or distilled water 10 times the volume of the resin column, and then washed with 5 times the volume of the resin column Elute with 95% ethanol by volume, collect the ethanol eluate, remove the solvent to obtain the raw material drug; add starch or dextrin to compress into tablets.
为解决上述技术问题,本发明还提供一种治疗绝经妇女骨质疏松症的中药组合物的剂型,药物剂型可以为:糖衣片剂、薄膜衣片剂、肠溶衣片剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、冲剂、蜜丸剂、散剂、丹剂、注射剂、栓剂、硬膏剂、糖浆剂、针粉剂或缓释胶囊剂。 In order to solve the above-mentioned technical problems, the present invention also provides a dosage form of a traditional Chinese medicine composition for treating postmenopausal women's osteoporosis, and the pharmaceutical dosage form can be: sugar-coated tablet, film-coated tablet, enteric-coated tablet, hard capsule, Soft capsules, oral liquids, buccal preparations, granules, granules, honeyed pills, powders, elixirs, injections, suppositories, plasters, syrups, injection powders or sustained-release capsules. the
本发明涉及中药制剂的药理及药性如下: The present invention relates to the pharmacology and property of medicine of Chinese medicine preparation as follows:
枇杷芋 Loquat taro
【性味】《陕西中草药》:"涩微苦,温,有小毒。" [nature and flavor] "Shaanxi Chinese Herbal Medicine": "astringent, slightly bitter, warm, slightly poisonous."
【功用主治】温肾,消胀,止痛。治腹胀,胃痛,疝气,劳伤咳嗽,血吸虫病。 ①《陕西中草药》:"理气止痛,止咳化痰,消胀健胃。治腹胀,胃痛,疝气,劳伤咳嗽。" ②《西藏常用中草药》:"补肾助阳,强筋骨。治腰酸腿痛,阳痿。" [Functions and Indications] Warming the kidney, reducing swelling and relieving pain. Treatment of abdominal distension, stomach pain, hernia, overworked cough, schistosomiasis. ①"Shaanxi Chinese Herbal Medicine": "Regulate qi and relieve pain, relieve cough and reduce phlegm, relieve swelling and invigorate the stomach. Treat abdominal distension, stomach pain, hernia, and cough due to overwork." ②"Chinese herbal medicine commonly used in Tibet": "Tonify kidney and yang, strengthen muscles and bones. Treat backache and leg pain , impotence."
覆盆子: raspberry:
【性味】温;甘、酸;归肾、膀胱经。 [nature and flavor] warm; sweet, sour; return kidney, urinary bladder channel.
【功能主治】益肾,固精,缩尿。用于肾虚遗尿,小便频数,阳痿早泄,遗精滑精。 [Functions and Indications] Tonifying the kidney, strengthening essence, reducing urination. For kidney deficiency enuresis, frequent urination, impotence and premature ejaculation, nocturnal emission and spermatorrhea. the
菟丝子: Cuscuta:
【性味】甘辛平,入肝、肾经。 [nature and flavor] Ganxinping, enters liver and kidney channels.
【功能主治】补肾益精,养肝明目,安胎。用于肝肾亏虚,腰膝酸痛,阳痿遗精,尿频遗尿,两目昏暗,胎动不安等症。 [Functions and Indications] Tonifying the kidney and replenishing essence, nourishing the liver and improving eyesight, preventing miscarriage. For liver and kidney deficiency, waist and knee pain, impotence and nocturnal emission, frequent urination and enuresis, dim eyesight, restless fetal movement and other diseases. the
栗子: chestnut:
【性味归经】性温,味甘平;入脾、胃、肾经。 [meridian distribution of nature and flavor] warm in nature, sweet and flat in taste; enters the spleen, stomach, and kidney channels. the
【功效主治】养胃健脾,补肾强筋,;主治反胃不食,泄泻痢疾,吐血,衄血,便血,筋伤骨折瘀肿、疼痛,瘰疬肿毒等病症。《食物本草》:“主益气,厚肠胃,补肾气,令人耐饥。” [Efficacy and Indications] Nourishing the stomach and strengthening the spleen, tonifying the kidney and strengthening the tendons; mainly treating nausea and indigestion, diarrhea and dysentery, vomiting blood, epistaxis, blood in the stool, muscle injury, fracture, bruise, pain, scrofula and other diseases. "Food Materia Medica": "Mainly nourishes qi, thickens the stomach, nourishes kidney qi, and makes people resistant to hunger."
枸杞子: Wolfberry:
【性味】甘,平,入肝、胃二经,兼入肺经; [nature and flavor] sweet, flat, enter liver, stomach two meridians, concurrently enter lung meridian;
【功能主治】补肾益精,养肝明目,补血安神,生津止渴,润肺止咳。主治:治中风眩晕,虚劳,诸见血证,咳嗽血,痿、厥、挛,消瘴,伤燥,遗精,赤白浊,脚气,鹤膝风。 [Functions and Indications] Tonifying kidney and essence, nourishing liver and improving eyesight, nourishing blood to calm nerves, promoting body fluid to quench thirst, moistening lung and relieving cough. Indications: Treatment of apoplexy, dizziness, asthenia, various blood syndromes, cough with blood, flaccidity, syncope, contracture, dispelling miasma, dryness, nocturnal emission, red and white turbidity, beriberi, crane knee wind.
女贞子: Ligustrum:
【性味归经】味苦、甘, 性平,入肝、肾经; [meridian distribution of nature and flavor] taste bitter, sweet, neutral in nature, enter the liver and kidney channels;
【功效】滋阴补肾。 【Efficacy】Nourishing yin and tonifying kidney.
黄精: Polygonatum:
【性味】甘,平;归肺,脾,肾经。 [nature and flavor] sweet, flat; Return lung, spleen, kidney channel.
【功能主治】滋肾润脾,补脾益气。阴虚劳嗽;肺燥咳嗽;脾虚乏力;食少口干;消渴;肾亏腰膝酸软;阳痿遗精;耳鸣目暗;须发早白;体虚赢瘦;风癞癣疾。 [Functions and Indications] Nourishes the kidney and moistens the spleen, nourishes the spleen and replenishes qi. Cough due to yin deficiency; lung dryness cough; spleen deficiency and fatigue; lack of food, dry mouth; thirst; kidney deficiency, soreness of the waist and knees; the
淫羊藿: Epimedium:
【味性归经】辛、甘,温。归肝、肾经; [Taste Meridian Distribution] Pungent, sweet, warm. Return liver, kidney meridian;
【主治功能】补肾阳,强筋骨,祛风湿。 【Indications】Invigorating kidney yang, strengthening muscles and bones, dispelling rheumatism.
淫羊藿茎叶含有淫羊藿甙和挥发油。经证实,淫羊藿有雄性激素样的作用,其功效强于蛤蚧和海马。临床显示,它通过促进精液分泌,使精囊充满精液后,反过来又能刺激感觉神经,从而激发性欲而致阴茎勃起。同时,淫羊藿还可以抑制血管运动中枢,扩张周围血管,使血压下降,并能镇咳、祛痰、平喘,对脊髓灰质炎病毒、白色葡萄球菌、金黄色葡萄球菌等也有显著的抑制作用。 Epimedium stems and leaves contain icariin and volatile oil. It has been confirmed that Epimedium has a male hormone-like effect, and its efficacy is stronger than that of Gecko and hippocampus. It has been clinically shown that by promoting the secretion of semen, the seminal vesicles are filled with semen, which in turn can stimulate the sensory nerves, thereby stimulating sexual desire and causing penile erection. At the same time, Epimedium can also inhibit the vasomotor center, expand peripheral blood vessels, lower blood pressure, relieve cough, eliminate phlegm, and relieve asthma. effect. the
淫羊藿在临床上主要用于治疗生殖、骨关节、呼吸系统疾病。淫羊藿配伍熟地、当归、白术、枸杞、杜仲、仙茅、巴戟天、山茱萸、蛇床子、韭菜子、肉苁蓉、制附子、肉桂,称为“赞育丹”,可治阳痿、早泄。淫羊藿配伍威灵仙、苍耳子、川芎,可治关节疼痛。淫羊藿不拘多少,煎汤漱口,可治牙痛。取淫羊藿加矮地茶煎汤服用,可治慢性支气管炎,其祛痰镇咳作用比较明显。取淫羊藿与黄芪、党参、附子、细辛、麻黄等煎煮同用,可治病态窦房结综合征和房室传导阻滞。 Epimedium is mainly used clinically to treat reproductive, bone and joint, and respiratory diseases. Epimedium is compatible with rehmannia glutinosa, angelica, Atractylodes macrocephala, wolfberry, Eucommia, curculigo, Morinda officinalis, dogwood, cnidium, leek seeds, cistanche, aconite, cinnamon, called "Zanyu Dan", which can cure impotence and premature ejaculation. Epimedium is compatible with Clematis, Xanthium, and Chuanxiong, which can cure joint pain. Regardless of the amount of Epimedium, decoction and gargle can cure toothache. Taking epimedium plus Aodi tea decoction can cure chronic bronchitis, and its expectorant and antitussive effects are more obvious. Taking Epimedium and decocting with Astragalus, Codonopsis, Aconite, Asarum, Ephedra, etc. can treat sick sinus syndrome and atrioventricular block. the
雪莲花: Snow lotus:
【性味】维吾尔医:性质,二级湿热。中医:微苦,温。 [nature and flavor] Uighur medicine: nature, secondary damp heat. Chinese medicine: slightly bitter, warm. the
【功能与主治】维吾尔医:补肾活血,强筋骨,营养神经,调节异常体液。用于风湿性关节炎,关节疼痛,肺寒咳嗽,肾与小腹冷痛,白带过多等。中医:温肾助阳,祛风胜湿,通经活血。用于风塞湿痹痛、类风湿性关节炎,小腹疼痛,月经不调。 [Functions and Indications] Uighur medicine: Tonify kidney and activate blood, strengthen muscles and bones, nourish nerves, regulate abnormal body fluids. For rheumatoid arthritis, joint pain, lung cold cough, kidney and lower abdomen cold pain, excessive leucorrhea, etc. Traditional Chinese Medicine: Warming the kidneys and supporting yang, expelling wind and dampness, promoting menstrual flow and promoting blood circulation. For wind block damp arthralgia, rheumatoid arthritis, lower abdomen pain, irregular menstruation. the
各地民间将雪莲花全草入药,主治雪肓、牙痛、风湿性关节炎、阳痿、月经不调、红崩、白带等症。印度民间还雪莲花来治疗许多慢性病患者。如胃溃疡、痔疮、支气管炎、心脏病、鼻出血和蛇咬伤等症。在藏医藏药上雪莲花作为药物已有悠久的历史。藏医学文献《月王药珍》和《四部医典》上都有记载。有祛风湿性关节炎,除寒化痰、壮阳补血、温暖子宫等功能。主治雪肓、牙痛、风湿性关节炎、阳萎、月经不调、红崩、白带等症。印度民间还用雪莲花来治疗许多慢性病患者。如胃溃疡、痔疮、支气管炎、心脏病、鼻出血和蛇咬伤等症。在藏医藏药上雪莲花作为药物已有悠久的历史。早在清代《本草纲目拾遗》中已有对雪莲花的记载,称雪莲“性大热、能补精益阳”。经现代化化学成分分析,雪莲花草含生物碱、黄酮、兹醇、挥发油,含原糖和十六种氨基酸等等,其主要功能有散寒除湿、止痛、活血通经、暖宫散淤、强筋助阳,对医疗风湿疾病有特殊疗效。另经临床药学研究实践证明,雪莲花草入药,具有通经活血,暧宫散淤、散寒除湿、强筋助阳、止血、消肿之功能。对治疗急慢性风湿性关节炎引起的疼痛、肺寒咳嗽、宫寒腹痛、闭经、胎衣不下、阳痿和麻疹不透等症。 Folks from all over the country use the whole herb of snow lotus as medicine to treat snow blindness, toothache, rheumatoid arthritis, impotence, irregular menstruation, red collapse, leucorrhea and other diseases. Indian folks also use snow lotus to treat many chronic diseases. Such as stomach ulcers, hemorrhoids, bronchitis, heart disease, epistaxis and snake bites. Snow lotus has a long history as a medicine in Tibetan medicine. It is recorded in the Tibetan medical literature "Yuewang Yaozhen" and "Four Medical Codes". It has the functions of dispelling rheumatic arthritis, removing cold and reducing phlegm, strengthening yang and enriching blood, and warming the uterus. Indications snow blindness, toothache, rheumatoid arthritis, impotence, irregular menstruation, red menstrual bleeding, leucorrhea embolism. Indian folks also use snow lotus to treat patients with many chronic diseases. Such as stomach ulcers, hemorrhoids, bronchitis, heart disease, epistaxis and snake bites. Snow lotus has a long history as a medicine in Tibetan medicine. As early as in the Qing Dynasty "Compendium of Materia Medica Supplements", there has been a record of snow lotus, saying that snow lotus is "hot in nature, can nourish lean and benefit yang". According to modern chemical composition analysis, snow lotus herb contains alkaloids, flavonoids, zirconols, volatile oils, raw sugar and 16 kinds of amino acids, etc., and its main functions include dispelling cold and dehumidification, relieving pain, promoting blood circulation and stimulating menstruation, warming the palace and dispelling silt, strengthening Tendons help yang and have special curative effects on treating rheumatic diseases. In addition, it has been proved by clinical pharmacy research that snow lotus flowers and herbs are used as medicines, which have the functions of dredging menstruation and activating blood circulation, warming the uterus and dispelling stasis, dispelling cold and dehumidification, strengthening muscles and yang, stopping bleeding and reducing swelling. For the treatment of pain caused by acute and chronic rheumatoid arthritis, cough due to lung cold, abdominal pain due to cold palace, amenorrhea, retained placenta, impotence and impervious measles. the
巴戟天: Morinda:
【性味】味辛,甘; 性微温; 归肾,肝经。 [nature and flavor] acrid in the mouth, sweet; Slightly warm in nature; Return kidney, liver meridian.
【功用】补肾助阳,祛风除湿,强筋健骨。主治 阳痿遗精、宫冷不孕、月经不调、少腹冷痛、风湿痹痛、筋骨痿软。 [Function] Tonify kidney and support yang, dispel wind and dampness, strengthen tendons and bones. Indications Impotence and nocturnal emission, cold uterine infertility, irregular menstruation, cold pain in the lower abdomen, rheumatic arthralgia, muscle and bone flaccidity. the
仙茅: Curculigo:
【性味】辛,温,有毒。入肾、肝经。 [nature and flavor] pungent, warm, poisonous. Go into kidney, Liver Channel. the
【功能主治】温肾阳,壮筋骨。治阳萎精冷,小便失禁,崩漏,心腹冷痛,腰脚冷痹,痈疽,瘰疬,阳虚冷泻。阳痿精寒,腰膝风冷,筋骨痿痹等症。 [functions and indications] warming kidney yang, strengthening muscles and bones. Treatment of impotence and cold essence, urinary incontinence, metrorrhagia, confidant cold pain, cold arthralgia of waist and feet, carbuncle, scrofula, yang deficiency and cold diarrhea. Impotence and essence-cold, wind-cold waist and knees, muscle and bone flaccidity and numbness embolism. the
老鹳草: Geranium:
【性味】辛、苦,平。 [nature and flavor] pungent, bitter, flat. the
【归经】归肝、肾、脾经。 [return through] returns liver, kidney, spleen channel. the
【功能主治】祛风湿,通经络,止泻利。用于风湿痹痛,麻木拘挛,筋骨酸痛,泄泻痢疾。 [function cures mainly] wind-damp dispelling, meridian dredging, antidiarrheal beneficial. For rheumatic arthralgia, numbness and spasm, muscle and bone pain, diarrhea and dysentery.
乌药叶: Herba Leaf:
【性味归经】辛、温入肺、脾、肾三经; [meridian distribution of nature and flavor] pungent and warm enter the lung, spleen and kidney meridians;
【功效主治】温中,理气,止痛。治腹中寒痛,小便滑数,食积,风湿关节痛。 [Efficacy and Indications] Warming the middle, regulating qi, relieving pain. Control cold and pain in the abdomen, frequent urination, indigestion, rheumatism and arthralgia.
乌药配伍效用:乌药配伍沉香 乌药温肾散寒、行气止痛;沉香醒脾开胃、祛湿化浊、行气止痛.二药合用, 走气分、达下焦, 有醒脾散寒、行气止痛之功效, 用於治疗肝郁脾虚之胸闷、腹胀、气短、乏力、呕吐等症. Compatibility effect of black medicine: black medicine compatibility with agarwood: black medicine warms the kidney and dispels cold, promotes qi and relieves pain; Combination of the two medicines, move the qi, reach the lower burner, have the effect of waking the spleen and dispelling cold, promoting qi and relieving pain. It is used to treat chest tightness, abdominal distension, shortness of breath, fatigue, vomiting and other symptoms of liver depression and spleen deficiency. the
乌药配伍当归 乌药辛开温通, 行气解郁、散寒止痛, 偏走气分;当归辛散温运, 养血活血、调经止痛, 偏走血分.二者伍用, 共奏行气活血、散寒温经止痛之功效, 用於治疗寒凝气滞血淤之痛经、产后腹痛以及寒疝等症. Compatibility of black medicine with angelica Wuyao is pungent and warm, promotes qi and relieves depression, dispels cold and relieves pain, and diverts qi; Angelica pungent dissipates and warms, nourishes blood and activates blood, regulates menstruation and relieves pain, and deviates from blood. The combination of the two plays the effect of promoting qi and blood circulation, dispersing cold and warming the meridian, and relieving pain. It is used to treat dysmenorrhea, postpartum abdominal pain, and cold colic caused by cold condensate, qi stagnation, and blood stasis.
乌药配伍木香 乌药行气止痛散寒, 长於温散下焦寒湿;木香行气止痛, 功擅行脾胃气滞.两药相须为用, 其散寒、行气、止痛之功效更著, 用於治疗寒凝气滞所致之脘腹胀痛以及胃肠神经官能症属气滞不通者. Wuyao is compatible with woody incense. Wuyao promotes qi, relieves pain and dispels cold, and is better than warming and dissipating cold and dampness in the lower burner; woody fragrance promotes qi and relieves pain, and is good at promoting spleen and stomach qi stagnation. The two medicines must be used together, and their effects of dispelling cold, promoting qi, and relieving pain are more pronounced. It is used to treat abdominal distension and pain caused by cold stagnation and stagnation of qi, and gastrointestinal neurosis is caused by stagnation of qi.
乌药配伍薤白 乌药行气止痛散寒;薤白通阳散结行气.二者伍用, 有行气通阳、止痛散寒之功效, 用於治疗阴寒痰浊凝滞所致之胸痹而症见胸闷、疼痛者. Compatibility of Wuyao with Xiebai: Wuyao promotes qi, relieves pain and dispels cold; The combination of the two has the effect of promoting qi and promoting yang, relieving pain and dispelling cold. It is used to treat chest pain caused by stagnation of phlegm and phlegm due to yin and cold.
乌药配伍益智仁 乌药温肾散寒;益智仁补肾缩尿.二者伍用, 有温补肾阳、散寒缩尿之功效, 用於治疗肾阳虚衰之尿频、遗尿等. Wuyao is compatible with Yizhiren: Wuyao warms the kidney and dispels cold; Yizhiren nourishes the kidney and reduces urine. The combination of the two has the effect of warming and nourishing kidney yang, dispelling cold and reducing urination, and is used to treat frequent urination and enuresis due to kidney yang deficiency.
沉香: Agarwood:
【性味归经】辛、苦,温。归脾、胃、肾、肺经 [meridian distribution of property and flavor] pungent, bitter, warm. Return spleen, stomach, kidney, lung meridians
【功 效】降气温中,暖肾纳气。 【Efficacy】Reduces the temperature, warms the kidney and absorbs qi. the
【主 治】治气逆喘息,呕吐呃逆,脘腹胀痛,腰膝虚冷,大肠虚秘,小便气淋,男子精冷。① 《别录》:“疗风水毒肿,去恶气。” [Indications] Treatment of dyspnea and wheezing, vomiting and hiccups, epigastric distension and pain, cold waist and knees, large intestine deficiency and constipation, stranguria in urination, and coldness in men. ① "Bie Lu": "Treat wind, water, poison and swelling, and remove bad breath."
路路通: Passepartout:
【性味归经】苦,平。归肝、肾经。 [meridian distribution of property and flavor] bitter, flat. Return liver, kidney channel.
【功能主治】祛风活络,利水通经。用于关节痹痛,麻木拘挛,水肿胀满,乳少经闭。 [Functions and Indications] Dispelling wind and activating collaterals, diuresis and dredging menstrual flow. For arthralgia, numbness and spasm, edema and fullness, breast oligomenorrhea. the
壁虎: gecko:
【性味归经】咸,寒。有小毒。 [meridian distribution of property and flavor] salty, cold. It is slightly poisonous.
【功能主治】祛风,活络,散结。用于中风瘫痪,风湿关节痛,骨髓炎,淋巴结结核,肿瘤。 [function cures mainly] expelling wind, activating collaterals, dispelling stagnation. For stroke paralysis, rheumatic joint pain, osteomyelitis, lymph node tuberculosis, tumor. the
鳖甲: Turtle shell:
【性味】 咸、寒。 [nature and flavor] salty, cold. the
【功用】滋肾潜阳,软坚散结。 [Function] Nourishes the kidney and subdues the yang, softens the hard mass and relieves stagnation. the
【主治】滋阴潜阳,软坚散结,退热除蒸。用于阴虚发热,劳热骨蒸,虚风内动,经闭,癓瘕,久疟疟母。《别录》:疗温疟,血瘕,腰痛,小儿胁下坚。《药性论》:主宿食、症块、痃癖气、冷瘕、劳瘦,下气,除骨热,骨节间劳热,结实壅塞。治妇人漏下五色赢瘦者。《日华子本草》:去血气,破感结、恶血,堕胎,消疮肿并扑损疚血,疟疾,肠痈。《本草衍义补遗》:补阴补气。《医学入门》:主劳疟、老疟、女子经闭,小儿痫疾。《纲目》:除老疟疟母,阴毒腹痛,劳复,食复,斑痘烦喘,妇人难产,产后阴脱,丈夫阴疮,石淋;敛溃痈。《江西中药》:治软骨病。 【Indications】Nourishing yin and suppressing yang, softening hard masses and resolving stagnation, reducing fever and removing steam. For yin deficiency and fever, labor heat bone steaming, internal movement of asthenia wind, amenorrhea, lumps in the abdomen, and chronic malaria malaria. "Bie Lu": treat febrile malaria, blood in the abdomen, lumbago, and children's hypochondrium. "Theory of Medicinal Properties": main food, lumps, obsessive qi, cold lumps, labor and emaciation, lowering qi, removing bone heat, labor heat between joints, firmness and congestion. The cured woman missed the five colors to win the thin one. "Nihuazi Materia Medica": remove blood energy, loose feeling knot, bad blood, abortion, reduce sores and swollen blood, malaria, intestinal carbuncle. "Materia Medica Yanyi Supplement": nourishing yin and nourishing qi. "Introduction to Medicine": mainly labor malaria, old malaria, women's amenorrhea, and children's epilepsy. "Compendium": In addition to the old malaria malaria mother, insidious abdominal pain, fatigue recovery, food recovery, spot pox and dyspnea, woman's dystocia, postpartum vaginal prolapse, husband's vulva sore, stone stranguria; astringe ulcer carbuncle. "Jiangxi Traditional Chinese Medicine": treat rickets.
豨莶草: Wexgrass:
【功能】祛风湿,利关节,解毒。 [function] dispelling rheumatism, benefiting joints, detoxification. the
【主治】用于风湿痹痛、筋骨无力 、腰膝酸软、四肢麻痹、半身不遂、风疹湿疮。 [Indications] For rheumatic arthralgia, weakness of muscles and bones, weakness of waist and knees, paralysis of limbs, hemiplegia, rubella eczema.
丹参: Danshen:
【性味归经】苦,微寒。归心、肝经。 [meridian distribution of property and flavor] bitter, slightly cold. GUIXIN, Liver Channel.
【功能主治】祛瘀止痛,活血通经,清心除烦。用于月经不调,经闭痛经, 症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠;肝脾肿大,心绞痛。《本草正义》:丹参,《本经》谓之微寒,陶弘景已疑其误,缪仲醇亦疑之,至张石顽乃改作微温。《本经》:主心腹邪气,肠鸣幽幽如走水,寒热积聚;破症除瘕,止烦满,益气。《吴普本草》:治心腹痛。《别录》:养血,去心腹痼疾结气,腰脊强,脚痹;除风邢留热,久服利人。 陶弘景:渍酒饮之,疗风痹。《药性论》:治脚弱,疼痹,主中恶;治腹痛,气作声音鸣吼。《日华子本草》:养神定志,通利关脉。治冷热劳,骨节疼痛,四肢不遂;排脓止痛,生肌长肉;破宿血,补新生血;安生胎,落死胎;止血崩带下,调妇人经脉不匀,血邪心烦;恶疮疥癣,瘿赘肿毒,丹毒;头痛,赤眼,热温狂闷。《滇南本草》:补心定志,安神宁心。治健忘怔忡,惊悸不寐。《纲目》:活血,通心包络。治疝痛。《云南中草药选》:活血散瘀,镇静止痛。治月经不调,痛经,风湿痹痛,子宫出血,吐血,乳腺炎,痈肿。 [Functions and Indications] Dispelling blood stasis and relieving pain, promoting blood circulation and promoting menstrual flow, clearing away heart-fire and relieving restlessness. Used for irregular menstruation, amenorrhea dysmenorrhea, accumulation of lumps in the abdomen, tingling pain in the chest and abdomen, heat pain, sore swelling and pain, restlessness and insomnia; hepatosplenomegaly, angina pectoris. "Materia Medica Justice": Danshen, "The Classic" called it slightly cold, Tao Hongjing suspected it was wrong, Miao Zhongchun also suspected it, and Zhang Shiwan changed it to lukewarm. "Herbal Classic": main confidant evil spirits, borborygmus faint like running water, accumulation of cold and heat; dispelling symptoms and removing lumps in the abdomen, stopping restlessness and fullness, benefiting qi. "Wu Pu Materia Medica": controls abdominal pain. "Bie Lu": Nourishes blood, removes stagnation of qi, strong waist and spine, and numbness of feet; removes wind and heat and keeps heat, long-term use benefits people. Tao Hongjing: Drink it with soaked wine to treat wind numbness. "Medicine Properties": Treat weak feet, pain and numbness, and control evil in the middle; cure abdominal pain, and make the sound of qi. "Rihuazi Materia Medica": nourish the mind and set the will, and benefit the Guanmai. Treat cold and heat fatigue, joint pain, limb paralysis; expel pus and relieve pain, promote muscle growth; break old blood, replenish new blood; induce birth, stop stillbirth; Evil sores and scabies, galls and swollen poisons, erysipelas; headache, red eyes, fever, temperature, maddening and stuffy. "Southern Yunnan Materia Medica": Replenish the mind and set the mind, soothe the nerves and calm the mind. Treat forgetfulness and palpitations, palpitations and insomnia. "Compendium": promoting blood circulation, Tongxin Envelope. Treat colic. "Yunnan Chinese Herbal Medicine Selection": promoting blood circulation and dispelling blood stasis, sedating and relieving pain. Control irregular menstruation, dysmenorrhea, rheumatic arthralgia, uterine bleeding, vomiting blood, mastitis, carbuncle. the
芝麻: Sesame:
药经记载Medicinal records
《神农本草经》说,芝麻主治“伤中虚赢,补五内、益气力、长肌肉、填精益髓。” "Shen Nong's Materia Medica" says that sesame seeds are mainly used to treat "injury and deficiency, tonify the five internal organs, strengthen energy, grow muscles, and fill the essence."
《抱朴子》:耐风湿,补衰老。 "Baopuzi": resists rheumatism, nourishes aging.
《本草纲目》:胡麻取油,以白者为胜,服食以黑者为良。 "Compendium of Materia Medica": Take oil from flax, the white one is the best, and the black one is good for taking. the
《本草从新》:胡麻服之令人肠滑,精气不固者亦勿宜食。 "Materia Medica Congxin": Taking flax makes the intestines slippery, and those whose energy is weak should not eat it. the
《本草求真》:下元不固而见便溏,阳痿,精滑,白带,皆所忌用。 "Materia Medica Seeking Truth": It is contraindicated for loose stools, impotence, leucorrhea, and leucorrhea due to infirmity in the lower Yuan. the
古代养生学家陶弘景曾说:八谷之中,惟此为良,仙家作饭饵之,断谷长生。 Tao Hongjing, an ancient health-preserving expert, once said: Among the eight grains, this is the only one that is good. Immortals use it as food bait, and if you break the grain, you will live forever. the
在中国古代,芝麻历来被视为延年益寿食品,宋代大诗人苏东坡也认为,芝麻能强身体,抗衰老,以九蒸胡麻,同去皮茯苓,少入白蜜为面食,日久气力不衰,百病自去,此乃长生要诀。 In ancient China, sesame has always been regarded as a food for prolonging life. The great poet Su Dongpo of the Song Dynasty also believed that sesame can strengthen the body and resist aging. Going away from illness is the key to longevity. the
食疗作用Therapeutic effect
芝麻味甘、性平,入肝、肾、肺、脾经。 Sesame is sweet in taste and flat in nature, and enters the liver, kidney, lung, and spleen meridians.
有补血明目、祛风润肠、生津通乳、益肝养发、强身体,抗衰老之功效。 It has the effects of nourishing blood and improving eyesight, dispelling wind and moistening intestines, promoting body fluid and unblocking milk, nourishing liver and hair, strengthening the body, and anti-aging. the
可用于治疗身体虚弱、头晕耳鸣、高血压、高血脂、咳嗽、身体虚弱、头发早白、贫血萎黄、津液不足、大便燥结、乳少、尿血等症。 It can be used to treat symptoms such as physical weakness, dizziness and tinnitus, high blood pressure, high blood fat, cough, physical weakness, premature graying of hair, anemia and chlorosis, insufficient body fluid, dry stool, less milk, and hematuria. the
[用途]用于肝肾虚损,精血不足,须发早白,眩晕耳鸣,腰膝酸软,四肢无力;产后血虚,乳汁不足;血虚津亏,肠燥便秘等。 [Use] Used for liver and kidney deficiency, insufficient essence and blood, premature graying of beard and hair, dizziness and tinnitus, soreness of waist and knees, weakness of limbs; postpartum blood deficiency, insufficient milk; blood deficiency and fluid loss, intestinal dryness and constipation, etc. the
一叶萩: Hagi One Leaf:
【功 效】:活血舒筋,健脾益肾。 【Efficacy】: Promote blood circulation and relax tendons, invigorate spleen and kidney. the
【性味归经】:辛苦,温,有毒。《湖南药物志》“甘微辛,温。”入肝、肾、脾三经 [meridian distribution of nature and flavor]: hard, warm, poisonous. "Hunan Drug Records" "sweet, slightly pungent, warm." Enters the liver, kidney, spleen three meridians
【用法用量】:内服:煎汤,3~5钱。 [Usage and Dosage]: Oral administration: Decoction, 3-5 qian. the
【药物配伍】:配独活,祛风胜湿;配当归,性温而散;配仙灵脾,补肾壮阳。 [Drug Compatibility]: with Duhuo, expelling wind and dampness; with Angelica, warm and loose; with Xianling Spleen, tonify kidney and strengthen yang. the
仙灵脾: Fairy Spleen:
【性味】辛、寒、无毒。 [nature and flavor] pungent, cold, nontoxic.
【功用】壮阳活血,祛风除湿。 [Function] Strengthening yang and promoting blood circulation, expelling wind and dampness. the
【主治】①肝肾亏虚,不能温养,气血运行受阻,风寒湿三邪乘袭所致的肢体关节疼痛,痛无定处,关节屈伸不利。②肾阳虚亏引起的腰部酸痛,下肢软弱无力。③中风后遗症出现的四肢不遂,皮肤麻木。 [Indications] ① Deficiency of the liver and kidney, unable to warm and nourish, obstructed circulation of qi and blood, and pain in limbs and joints caused by the three evils of wind, cold and dampness. ②Lower pain and lower limb weakness caused by deficiency of kidney yang. ③Limb paralysis and skin numbness in stroke sequelae. the
马尾千金草: Horsetail Herb:
【性味归经】:辛,温。入肝、肾二经。 [meridian distribution of property and flavor]: pungent, warm. Go into liver, kidney two warps. the
【功 效】:祛风除湿、消肿止痛。 【Efficacy】: Expelling wind and dampness, reducing swelling and relieving pain. the
【主 治】:跌打损伤;肌肉痉挛;筋骨疼痛;风湿关节痛;肥大性脊柱炎;类风湿性关节炎。 【Indications】: bruises; muscle spasm; muscle and bone pain; rheumatic joint pain; hypertrophic spondylitis; rheumatoid arthritis.
心叶荚蒾根: Heart leaf viburnum root:
【性味】湿,温。 [nature and flavor] wet, warm. the
【归经】入肝经。 [return through] enters Liver Channel. the
【功用主治】治风湿麻木,筋骨疼痛,跌损瘀凝,腰胁气胀。 [Functions and Indications] Treat rheumatism numbness, pain in muscles and bones, congealed blood stasis due to falls, flatulence in the waist and flanks. the
【用法与用量】内服:煎汤,5~7钱;或浸酒。 [Usage and Dosage] Oral administration: decoction, 5-7 qian; or soak in wine. the
【选方】治风湿筋骨疼痛:心叶荚蒾配五加皮;淫羊藿、松节、秦艽,泡酒服。 【Prescriptions】Treating rheumatism and pain in the muscles and bones: Viburnum cordifolia with Cortex Wujiapi;
双股箭: Double Arrow:
【性味】苦微辛涩,温。 [nature and flavor] bitter, slightly pungent, warm. the
【功用主治】祛风湿,舒筋络。治风湿筋骨疼痛,跌打损伤:双股箭三至五钱,水煎服,或外包疼痛处。 [function cures mainly] dispels wind-damp, relaxes tendons and collaterals. Treatment of rheumatism, muscle and bone pain, bruises: double-strand arrow three to five qian, decocted in water, or outsourced to the painful area.
桃仁: peach kernel:
【性味归经】性甘平、味苦,入肺、肝、大肠经; [meridian distribution of nature and flavor] sweet in nature, bitter in taste, enters the lung, liver, and large intestine meridians;
【功能主治】有破血行瘀,润燥滑肠的功效;治经闭、痛经、瘕瘕痞块,跌打损伤、肠燥便秘。 [Functions and Indications] It has the effects of dispelling blood and promoting blood stasis, moistening dryness and smoothing intestines; treating amenorrhea, dysmenorrhea, lumps in the abdomen, bruises, intestinal dryness and constipation.
大枣: Jujube:
【性味归经】甘,温,归脾、胃经; [meridian distribution of property and flavor] sweet, warm, return spleen, stomach meridian;
【功能主治】补中益气,养血安神。用于脾虚食少,乏力便溏,妇人脏躁。 [Functions and Indications] Tonify the middle and replenish qi, nourish blood and calm the nerves. It is used for spleen deficiency, lack of food, fatigue and loose stools, and women are dirty and irritable.
桑寄生: Sang Jisheng:
【性味】苦、甘,平。 [nature and flavor] bitter, sweet, flat. the
【归经】归肝、肾经。 [return through] returns liver, kidney channel. the
【功能主治】补肝肾,强筋骨,祛风湿,安胎元。用于风湿痹痛,腰膝酸软,筋骨无力,崩漏经多,妊娠漏血,胎动不安;高血压。 [Functions and Indications] Tonify the liver and kidney, strengthen bones and muscles, dispel rheumatism, and calm the fetus. For rheumatic arthralgia, soreness of the waist and knees, weakness of muscles and bones, metrorrhagia, bleeding during pregnancy, fetal movement; hypertension. the
桑椹: Mulberry:
【性味】甘,微寒;归心、肝、肾经。 [nature and flavor] sweet, slightly cold; GUIXIN, liver, kidney channel.
【功能主治】治肝肾阴亏,捎揭,便秘,目暗,耳鸣,原疡,关节不利。它有改善皮肤(包括头皮)血液供应,营养肌肤、使皮肤白嫩及乌发等作用,并能延缓衰老。桑椹是中老年人健体美颜、抗衰老的佳果与良药。常食桑椹可以明目,缓解眼睛疲劳干涩的症状。桑椹具有免疫促进作用。桑椹对脾脏有增重作用,对溶血性反应有增强作用,可防止人体动脉硬化、骨骼关节硬化,促进新陈代谢;桑椹可以促进血红细胞的生长,防止白细胞减少,并对治疗糖尿病、贫血、高血压、高血脂、冠心病、神经衰弱等病症具有辅助疗效。桑椹具有生津止渴、促进消化、帮助排便等作用,适量食用能促进胃液分泌,刺激肠蠕动及解除燥热。中医认为,桑椹性味甘寒,具有补肝益肾、生津润肠、乌发明目等功效。 [Functions and Indications] Treat liver and kidney yin deficiency, constipation, dark eyes, tinnitus, primary ulcer, and joint discomfort. It can improve the blood supply of the skin (including the scalp), nourish the skin, make the skin white and tender, black hair, etc., and can delay aging. Mulberry is a good fruit and good medicine for middle-aged and elderly people's body, beauty, and anti-aging. Regular consumption of mulberries can improve eyesight and relieve the symptoms of eye fatigue and dryness. Mulberry has immune-boosting effect. Mulberry fruit has a weight-increasing effect on the spleen, has a strengthening effect on hemolytic reactions, can prevent human arteriosclerosis, bone and joint sclerosis, and promotes metabolism; mulberry fruit can promote the growth of red blood cells, prevent leukopenia, and treat diabetes, anemia, hypertension , hyperlipidemia, coronary heart disease, neurasthenia and other diseases have auxiliary curative effect. Mulberry has the effects of promoting body fluid to quench thirst, promoting digestion, and helping defecation. Eating in moderation can promote the secretion of gastric juice, stimulate intestinal peristalsis and relieve dryness and heat. Traditional Chinese medicine believes that mulberry is sweet and cold in nature and has the effects of nourishing the liver and kidney, promoting body fluid and moistening the intestines, and blackening the eyes. the
蜂乳: Bee milk:
【性味】甘酸,平。 [nature and flavor] sweet and sour, flat.
【功用主治】滋补,强壮,益肝,健脾。治病后虚弱,小儿营养不良,老年体衰,传染性肝炎,高血压病,风湿关节炎,十二指肠溃疡。 [Functions and Indications] Nourishing, strengthening, benefiting the liver and invigorating the spleen. Weakness after treatment, malnutrition in children, frailty in the elderly, infectious hepatitis, hypertension, rheumatoid arthritis, duodenal ulcer. the
冬虫夏草: Cordyceps:
【性味】味甘,性平。 [nature and flavor] sweet in taste, flat in nature.
【功用】有滋阴润肺、补肾壮阳的作用,所以可以作为滋肺补肾、止血化痰、保肺、化痢、止痨嗽等调补的食品。虫草体内含虫草酸。维生素B12、脂肪、蛋白等。虫草性甘、温平、无毒,是著名的滋补强壮药,常用肉类炖食,有补虚健体之效。适用于治疗肺气虚和肺肾两虚、肺结核等所致的咯血或痰中带血、咳嗽。气短、盗汗等,对肾虚阳痿、腰膝酸疼等亦有良好的疗效,也是老年体弱者的滋补佳品。 [Function] It has the functions of nourishing yin and moistening lung, nourishing kidney and strengthening yang, so it can be used as nourishing food for nourishing lung and kidney, stopping bleeding and resolving phlegm, protecting lung, resolving dysentery, and relieving consumptive cough. Cordyceps contains cordycepic acid. Vitamin B12, fat, protein, etc. Cordyceps is sweet, warm and non-toxic. It is a famous tonic and strong medicine. It is often stewed with meat, which has the effect of tonifying deficiency and strengthening the body. It is suitable for the treatment of hemoptysis or bloody sputum and cough caused by lung qi deficiency, lung and kidney deficiency, tuberculosis, etc. Shortness of breath, night sweats, etc. It also has a good curative effect on kidney deficiency, impotence, waist and knee pain, etc. It is also a good nourishing product for the elderly and infirm. the
木瓜: pawpaw:
【归经】归肝、脾经。 [return through] returns liver, spleen channel.
【功能主治】平肝舒筋,和胃化湿,主治脾胃虚弱、食欲不振、乳汁缺少、关节痛疼、肢体麻木等症。 [Functions and Indications] Pinggan soothes tendons, harmonizes stomach and removes dampness, mainly treats symptoms such as weakness of spleen and stomach, loss of appetite, lack of milk, joint pain, and numbness of limbs. the
具体实施方式: Detailed ways:
实施例1,配方: Embodiment 1, formula:
枇杷芋1g、覆盆子1g、菟丝子5g、栗子1g、枸杞子5g、女贞子0.5g、黄精1g、淫羊藿1g、雪莲花0.1g、巴戟天0.01g、仙茅0.01g、老鹳草0.01g、乌药叶1g、沉香1g、路路通1g、壁虎1g、鳖甲1g、豨莶草0.01g、丹参1g、芝麻1g、一叶萩0.01g、仙灵脾0.01g、马尾千金草1g、心叶荚蒾根1g、双股箭0.01g、桃仁1g、大枣1g、桑寄生1g、桑椹10g、蜂乳10g、冬虫夏草1g、木瓜1g; Loquat taro 1g, raspberry 1g, dodder 5g, chestnut 1g, medlar 5g, privet privet 0.5g, sealwort 1g, epimedium 1g, snow lotus 0.1g, Morinda officinalis 0.01g, curculigo 0.01g, geranium Grass 0.01g, black medicine leaf 1g, agarwood 1g, passepartout 1g, gecko 1g, turtle shell 1g, scutellaria 0.01g, salvia miltiorrhiza 1g, sesame 1g, hagi 0.01g, fairy spleen 0.01g, horsetail daughter Grass 1g, heart leaf viburnum root 1g, double arrow 0.01g, peach kernel 1g, jujube 1g, mulberry 1g, mulberry 10g, bee milk 10g, cordyceps 1g, papaya 1g;
中药组合物的剂型为蜜炼丸剂的制备方法包括: The dosage form of the Chinese medicine composition is that the preparation method of honey refining pill comprises:
a、将除蜂乳外的原料药放入乙醇浸泡,热提取1次,成浸膏状,为组分1; a. Soak the raw materials except bee milk in ethanol, and heat extract once to form an extract, which is component 1;
b、药渣加水提取2次,浓缩过滤为浸膏状,为组分2; b. The dregs are extracted twice with water, concentrated and filtered to obtain an extract, which is component 2;
c、将上述两种浸膏浓缩成糊状,加蜂乳搓成丸剂。 c. Concentrate the above two extracts into a paste, add bee milk and knead into a pill.
所述步骤a中,将除蜂乳外的原料药加入5-10倍量的60-90%乙醇浸泡1-2小时,加热提取1-2小时,去上清液,药糊继续加热浓缩至浸膏状,静置备用,成为组分1。 In the step a, add 5-10 times the amount of 60-90% ethanol to the raw material medicine except bee milk, soak for 1-2 hours, heat and extract for 1-2 hours, remove the supernatant, continue heating and concentrating the medicine paste to In the form of extract, stand for later use and become component 1. the
所述步骤b中,可以将药渣加水浸泡1-2小时,提取两次,每次1-1.5小时,合并提取液, 80-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时 1.36的浸膏,加热浓缩,30分钟~45分钟,提取活性成份,将浓缩液静置成浸膏状,作为组分2。 In the step b, the dregs can be soaked in water for 1-2 hours, extracted twice, each time for 1-1.5 hours, and the extracts are combined, filtered at 80-120 mesh, and then ultrafiltered with a cut-off molecular weight of 5000-10000 Column ultrafiltration, the ultrafiltrate is concentrated under reduced pressure and the extract with a relative density of 1.36 at 80°C is heated and concentrated for 30 minutes to 45 minutes to extract the active ingredient, and the concentrated solution is left to stand to form an extract, which is used as component 2. the
动物局部刺激试验:Animal local irritation test:
本发明片剂的豚鼠皮肤过敏试验。结果表明:皮肤过敏试验,高剂量组0.8g(药粉)/kg、低剂量组0.1g(药粉) /kg,分别相当于拟临床人用量[0.04g(药粉)/kg]的20倍、2.5倍,经皮肤给药,均未见动物产生变态反应;直肠用药刺激性试验高剂量组5.0g(药粉) /kg,低剂量组3.2g(药粉)/kg,分别相当于拟临床人用量的125、80倍,在规定的时间内观察直肠粘膜均无充血、水肿等现象,病理组织学检查与空白对照组比较无明显差异,未见出现明显的刺激性反应,每组留存的部分动物其全身状况,体重、呼吸、循环、中枢神经系统及四肢活动等,均无明显异常反应。 Guinea pig skin allergy test of tablet of the present invention. The results show that: in skin allergy test, 0.8g (medicine powder)/kg in the high-dose group and 0.1g (medicine powder)/kg in the low-dose group are respectively equivalent to 20 times and 2.5 times the proposed clinical human dosage [0.04g (medicine powder)/kg]. times, through the skin administration, no animals were seen to produce allergic reactions; rectal administration irritation test high dose group 5.0g (medicine powder)/kg, low dose group 3.2g (medicine powder)/kg, respectively equivalent to proposed clinical human dosage 125, 80 times, the rectal mucosa was observed within the specified time without congestion, edema, etc., and there was no significant difference in histopathological examination compared with the blank control group, and no obvious irritating reaction was seen. General condition, body weight, breathing, circulation, central nervous system and limb activities, etc., showed no obvious abnormal reaction.
急性毒性试验Acute Toxicity Test
应用小鼠进行急性毒性实验表明:小鼠口服灌胃本发明的中药组合物的片剂,在488.8g生药/kg剂量下,给药后小鼠出现轻微活动减少,1小时左右恢复正常,给药后连续观察7天,无一动物死亡,其全身状况、饮食、摄水、小便和体重增长均正常,实验结果表明:小鼠口服灌胃本发明的中药制剂片剂的最大给药量为488.8g生药/kg/d(LD 50 >488.8g生药/kg)。本发明的中药制剂每日临床用药总量为0.1g生药/kg/d;按体重计,小鼠灌胃本发明的中药制剂的耐受量为临床病人的4888倍。提示该药急性毒性低,临床用药安全。 Application of mice to carry out acute toxicity test shows: the tablet of the traditional Chinese medicine composition of the present invention is orally administrated into mice, and under the dose of 488.8g crude drug/kg, after administration, the mice have a slight activity reduction, and return to normal in about 1 hour. Continuously observe 7 days after the medicine, no animal dies, and its general condition, diet, water intake, urination and weight gain are all normal. 488.8g crude drug/kg/d (LD 50 >488.8g crude drug/kg). The daily clinical dosage of the traditional Chinese medicine preparation of the present invention is 0.1 g crude drug/kg/d; in terms of body weight, the tolerated dose of the traditional Chinese medicine preparation of the present invention in mice is 4888 times that of clinical patients. It is suggested that the drug has low acute toxicity and is safe for clinical use.
典型病例及疗效 : Typical cases and curative effect:
秦某,女,年龄56岁,绝经后经常腰背疼痛,体力下降。2011年CT诊断腰间盘突出,2012年 CT 颈椎病,2013 年劳累后双膝关节肿痛,核磁检查 :骨质增生、半月板损伤。患者自述有时早晨双脚落地时脚痛并伴有肿胀感,近期晨起双手关节疼痛,但活动后能稍微缓解。今年 6 月 5日去医院检查骨密度 :腰椎 :L1-2.6、L2-2.3、L3-3.0、L4-3.0。患者服用本发明药物两个疗程后,关节疼痛、肿胀减轻,活动功能好转。 Qin, female, aged 56 years, often suffers from low back pain and decreased physical strength after menopause. Lumbar disc herniation was diagnosed by CT in 2011, cervical spondylosis by CT in 2012, swelling and pain of both knee joints after exertion in 2013, MRI examination: bone hyperplasia, meniscus injury. The patient reported that sometimes his feet hurt and swelled when he landed on the ground in the morning, and his hands and joints hurt in the morning recently, but it can be slightly relieved after activities. On June 5 this year, I went to the hospital to check the bone density: lumbar spine: L1-2.6, L2-2.3, L3-3.0, L4-3.0. After the patient takes the medicine of the present invention for two courses of treatment, joint pain and swelling are alleviated, and the activity function takes a turn for the better.
实施例2,配方: Embodiment 2, formula:
枇杷芋2g、覆盆子2g、菟丝子6g、栗子2g、枸杞子6g、女贞子0.6g、黄精2g、淫羊藿2g、雪莲花0.2g、巴戟天0.02g、仙茅0.02g、老鹳草0.02g、乌药叶2g、沉香2g、路路通2g、壁虎2g、鳖甲2g、豨莶草0.02g、丹参2g、芝麻2g、一叶萩0.02g、仙灵脾0.02g、马尾千金草2g、心叶荚蒾根2g、双股箭0.02g、桃仁2g、大枣2g、桑寄生2g、桑椹11g、蜂乳11g、冬虫夏草2g、木瓜2g; Loquat taro 2g, raspberry 2g, dodder 6g, chestnut 2g, medlar 6g, privet privet 0.6g, sealwort 2g, epimedium 2g, snow lotus 0.2g, Morinda officinalis 0.02g, curculigo 0.02g, geranium Grass 0.02g, black herb leaves 2g, agarwood 2g, Passepartout 2g, gecko 2g, turtle shell 2g, scutellaria 0.02g, salvia miltiorrhiza 2g, sesame 2g, Hagi 0.02g, fairy spleen 0.02g, horsetail daughter Grass 2g, heart leaf viburnum root 2g, double-strand arrow 0.02g, peach kernel 2g, jujube 2g, mulberry parasite 2g, mulberry 11g, bee milk 11g, cordyceps sinensis 2g, papaya 2g;
中药组合物的剂型为片剂的制备方法包括: The dosage form of the Chinese medicine composition is that the preparation method of tablet comprises:
将丹参放入10倍量乙醇中,加热回流提取2次,每次1~2小时,提取活性成份,将2次提取液合并静置;再取上述方中的剩余原料放入10倍量水中,加热回流提取3次,每次30分钟~1小时,将3次提取液合并静置;将上述两种提取液合并,减压回收乙醇并浓缩至药液浓度为0.5g生药/mL,抽滤后,滤液的相对密度约为1.08(20℃);上述滤液经体积为10L的大孔吸附树脂柱,先用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除溶剂,得到原料药;加入淀粉或糊精压片。 Put Salvia miltiorrhiza into 10 times the amount of ethanol, heat and reflux for extraction twice, each time for 1 to 2 hours, extract the active ingredients, combine the two extractions and let stand; then take the remaining raw materials in the above recipe and put them into 10 times the amount of water , heated and refluxed for 3 times, each time for 30 minutes to 1 hour, the three extracts were combined and left standing; the above two extracts were combined, ethanol was recovered under reduced pressure and concentrated until the concentration of the drug solution was 0.5g crude drug/mL, pumped After filtration, the relative density of the filtrate is about 1.08 (20°C); the above-mentioned filtrate passes through a macroporous adsorption resin column with a volume of 10L, and is first eluted with deionized water or distilled water 10 times the volume of the resin column, and then washed with 5 times the volume of the resin column Elute with 95% ethanol by volume, collect the ethanol eluate, remove the solvent to obtain the raw material drug; add starch or dextrin to compress into tablets.
急性毒性试验Acute Toxicity Test
应用小鼠进行急性毒性实验表明:小鼠口服灌胃本发明的中药组合物的胶囊剂,在488.8g生药/kg剂量下,给药后小鼠出现轻微活动减少,1小时左右恢复正常,给药后连续观察7天,无一动物死亡,其全身状况、饮食、摄水、小便和体重增长均正常,实验结果表明:小鼠口服灌胃本发明的中药制剂胶囊剂的最大给药量为488.8g生药/kg/d(LD 50 >488.8g生药/kg)。本发明的中药制剂每日临床用药总量为0.1g生药/kg/d;按体重计,小鼠灌胃本发明的中药制剂的耐受量为临床病人的4888倍。提示该药急性毒性低,临床用药安全。 Application of mice to carry out acute toxicity test shows: the capsules of the traditional Chinese medicine composition of the present invention are orally administrated into mice, and under the dose of 488.8g crude drug/kg, the mice have a slight activity reduction after administration, and return to normal in about 1 hour. Continuously observe 7 days after the medicine, no animal dies, and its general condition, diet, water intake, urination and weight gain are all normal. 488.8g crude drug/kg/d (LD 50 >488.8g crude drug/kg). The daily clinical dosage of the traditional Chinese medicine preparation of the present invention is 0.1 g crude drug/kg/d; in terms of body weight, the tolerated dose of the traditional Chinese medicine preparation of the present invention in mice is 4888 times that of clinical patients. It is suggested that the drug has low acute toxicity and is safe for clinical use.
实施例3,配方: Embodiment 3, formula:
枇杷芋5g、覆盆子5g、菟丝子10g、栗子3g、枸杞子10g、女贞子0.7g、黄精10g、淫羊藿10g、雪莲花0.5g、巴戟天0.05g、仙茅0.05g、老鹳草0.05g、乌药叶10g、沉香8g、路路通10g、壁虎3g、鳖甲10g、豨莶草0.05g、丹参12g、芝麻5g、一叶萩0.05g、仙灵脾0.05g、马尾千金草5g、心叶荚蒾根5g、双股箭0.05g、桃仁12g、大枣12g、桑寄生3g、桑椹12g、蜂乳12g、冬虫夏草3g、木瓜10g; Loquat taro 5g, raspberry 5g, dodder 10g, chestnut 3g, medlar 10g, privet privet 0.7g, sealwort 10g, epimedium 10g, snow lotus 0.5g, Morinda officinalis 0.05g, curculigo 0.05g, geranium Grass 0.05g, black herb leaves 10g, agarwood 8g, Passepartout 10g, gecko 3g, turtle shell 10g, scutellaria 0.05g, salvia miltiorrhiza 12g, sesame 5g, Hagi 0.05g, fairy spleen 0.05g, horsetail daughter Grass 5g, heart leaf viburnum root 5g, double arrow 0.05g, peach kernel 12g, jujube 12g, mulberry 3g, mulberry 12g, bee milk 12g, cordyceps 3g, papaya 10g;
中药组合物的剂型为片剂的制备方法包括: The dosage form of the Chinese medicine composition is that the preparation method of tablet comprises:
将丹参放入10倍量乙醇中,加热回流提取2次,每次1~2小时,提取活性成份,将2次提取液合并静置;再取上述方中的剩余原料放入10倍量水中,加热回流提取3次,每次30分钟~1小时,将3次提取液合并静置;将上述两种提取液合并,减压回收乙醇并浓缩至药液浓度为0.5g生药/mL,抽滤后,滤液的相对密度约为1.08(20℃);上述滤液经体积为10L的大孔吸附树脂柱,先用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除溶剂,得到原料药;加入淀粉或糊精压片。 Put Salvia miltiorrhiza into 10 times the amount of ethanol, heat and reflux for extraction twice, each time for 1 to 2 hours, extract the active ingredients, combine the two extractions and let stand; then take the remaining raw materials in the above recipe and put them into 10 times the amount of water , heated and refluxed for 3 times, each time for 30 minutes to 1 hour, the three extracts were combined and left standing; the above two extracts were combined, ethanol was recovered under reduced pressure and concentrated until the concentration of the drug solution was 0.5g crude drug/mL, pumped After filtration, the relative density of the filtrate is about 1.08 (20°C); the above-mentioned filtrate passes through a macroporous adsorption resin column with a volume of 10L, and is first eluted with deionized water or distilled water 10 times the volume of the resin column, and then washed with 5 times the volume of the resin column Elute with 95% ethanol by volume, collect the ethanol eluate, remove the solvent to obtain the raw material drug; add starch or dextrin to compress into tablets.
长期毒性试验:Long-term toxicity test:
选用SD大鼠,给予不同浓度(18.0、6.0、2.0g生药/kg)的本发明的中药制剂蜜丸剂,每天灌胃一次,连续90天,末次给药后24小时各组活杀1/2动物(雌雄各半),其余1/2动物继续观察2周后活杀。试验期间观察动物的外观、一般行为、摄食量、体重变化,给药后90天和停药2周进行血液学(RBC、HB、网织红细胞、PLT、CT、WBC及分类)和血液生化(AST、ALT、ALP、Glu、BUN、Crea、TP、T.BIL、ALB、CHOL)、尿液生化、脏器系数、病理组织学等指标检查。试验结果表明:本发明制剂在高、中、低剂量组动物一般状态良好,外观体征、行为活动、进食量和体重增长均无异常变化;三个剂量组及对照组血液学检查、血液生化学、尿液生化检查均在正常范围,组间无显著差异;各组主要脏器组织病理学检查未见明显异常。上述指标停药2周后也未见改变。本试验用药剂量分别为临床用药剂量的180、60、20倍,根据试验结果本发明的中药制剂在高、中、低三个剂量(18.0、6.0、2.0g生药/kg)连续90天给药对大鼠无明显影响,无明确的毒性靶器官和敏感指标,恢复期观察也未见延迟性毒性反应,提示本发明的中药制剂临床应用的剂量安全性较高。 Select SD rats for use, give different concentrations (18.0, 6.0, 2.0g crude drug/kg) of the Chinese medicine preparation honeyed pills of the present invention, gavage once a day, for 90 consecutive days, kill 1/2 of each group alive 24 hours after the last administration Animals (half male and half female), and the remaining 1/2 animals continued to be observed for 2 weeks before being killed alive. During the test, the appearance, general behavior, food intake and body weight changes of the animals were observed, and hematology (RBC, HB, reticulocyte, PLT, CT, WBC and classification) and blood biochemistry ( AST, ALT, ALP, Glu, BUN, Crea, TP, T.BIL, ALB, CHOL), urine biochemistry, organ coefficient, histopathology and other indicators inspection. The test results show that: the preparation of the present invention is in high, middle and low dose group animals in good general condition, and there are no abnormal changes in appearance signs, behavioral activities, food intake and body weight growth; Urine biochemical examinations were all within the normal range, and there was no significant difference between the groups; no obvious abnormalities were found in the histopathological examination of major organs in each group. The above indicators did not change after 2 weeks of drug withdrawal. The test dosage is respectively 180, 60, and 20 times of the clinical dosage, and according to the test results, the Chinese medicine preparation of the present invention is administered continuously for 90 days at high, medium and low dosages (18.0, 6.0, 2.0g crude drug/kg). It has no obvious effect on rats, no clear target organs of toxicity and sensitive indicators, and no delayed toxic reaction is observed in the recovery period, suggesting that the dose safety of the clinical application of the traditional Chinese medicine preparation of the present invention is relatively high.
典型病例及疗效 : Typical cases and curative effect:
章XX,女,50岁绝经,54岁检查骨密度-2.25,56岁检查骨密度-3.45,关节及腰有痛涨感,无蛀牙但咬牙力降低。患者服用本发明药物一个疗程后,症状消失,实验室检查骨密度 0.80,治愈。 Zhang XX, female, 50-year-old postmenopausal, 54-year-old bone density -2.25, 56-year-old bone density -3.45, joints and waist pain and swelling, no tooth decay but reduced tooth force. After the patient takes the medicine of the present invention for a course of treatment, the symptom disappears, and the bone mineral density of laboratory examination is 0.80, which is cured.
实施例4,配方: Embodiment 4, formula:
枇杷芋8g、覆盆子8g、菟丝子14g、栗子4g、枸杞子14g、女贞子0.8g、黄精14g、淫羊藿14g、雪莲花0.7g、巴戟天0.08g、仙茅0.08g、老鹳草0.08g、乌药叶14g、沉香9g、路路通14g、壁虎4g、鳖甲14g、豨莶草0.08g、丹参14g、芝麻8g、一叶萩0.08g、仙灵脾0.08g、马尾千金草8g、心叶荚蒾根8g、双股箭0.08g、桃仁14g、大枣14g、桑寄生4g、桑椹14g、蜂乳14g、冬虫夏草4g、木瓜14g; Loquat taro 8g, raspberry 8g, dodder 14g, chestnut 4g, medlar 14g, privet privet 0.8g, sealwort 14g, epimedium 14g, snow lotus 0.7g, Morinda officinalis 0.08g, curculigo 0.08g, geranium Grass 0.08g, black medicine leaves 14g, agarwood 9g, Passepartout 14g, gecko 4g, turtle shell 14g, scutellaria 0.08g, salvia miltiorrhiza 14g, sesame 8g, hagi 0.08g, fairy spleen 0.08g, horsetail daughter Grass 8g, heart leaf viburnum root 8g, double-strand arrow 0.08g, peach kernel 14g, jujube 14g, mulberry 4g, mulberry 14g, bee milk 14g, cordyceps 4g, papaya 14g;
所述中药组合物的剂型为蜜炼丸剂的制备方法包括: The dosage form of described Chinese medicine composition is that the preparation method of honey refining pill comprises:
步骤a,将除蜂乳外的原料药加入5-10倍量的60-90%乙醇浸泡1-2小时,加热提取1-2小时,去上清液,药糊继续加热浓缩至浸膏状,静置备用,成为组分1。 Step a, add 5-10 times the amount of 60-90% ethanol to the raw materials except bee milk, soak for 1-2 hours, heat and extract for 1-2 hours, remove the supernatant, and continue heating and concentrating the drug paste until it becomes an extract , let it stand for later use, and become component 1.
步骤b,可以将药渣加水浸泡1-2小时,提取两次,每次1-1.5小时,合并提取液, 80-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时 1.36的浸膏,加热浓缩,30分钟~45分钟,提取活性成份,将浓缩液静置成浸膏状,作为组分2。 In step b, soak the dregs in water for 1-2 hours, extract twice, each time for 1-1.5 hours, combine the extracts, filter with 80-120 mesh, and then ultrafilter through an ultrafiltration column with a cut-off molecular weight of 5000-10000 , the ultrafiltrate is concentrated under reduced pressure to the extract with a relative density of 1.36 at 80°C, heated and concentrated for 30 minutes to 45 minutes to extract the active ingredient, and the concentrated solution is left to stand to form an extract, which is used as component 2. the
步骤c,将上述两种浸膏浓缩成糊状,加蜂乳搓成丸剂。 Step c: Concentrate the above two extracts into a paste, add bee milk and knead into a pill. the
长期毒性试验:Long-term toxicity test:
选用SD大鼠,给予不同浓度(18.0、6.0、2.0g生药/kg)的本发明的中药制剂蜜丸剂,每天灌胃一次,连续90天,末次给药后24小时各组活杀1/2动物(雌雄各半),其余1/2动物继续观察2周后活杀。试验期间观察动物的外观、一般行为、摄食量、体重变化,给药后90天和停药2周进行血液学(RBC、HB、网织红细胞、PLT、CT、WBC及分类)和血液生化(AST、ALT、ALP、Glu、BUN、Crea、TP、T.BIL、ALB、CHOL)、尿液生化、脏器系数、病理组织学等指标检查。试验结果表明:本发明制剂在高、中、低剂量组动物一般状态良好,外观体征、行为活动、进食量和体重增长均无异常变化;三个剂量组及对照组血液学检查、血液生化学、尿液生化检查均在正常范围,组间无显著差异;各组主要脏器组织病理学检查未见明显异常。上述指标停药2周后也未见改变。本试验用药剂量分别为临床用药剂量的180、60、20倍,根据试验结果本发明的中药制剂在高、中、低三个剂量(18.0、6.0、2.0g生药/kg)连续90天给药对大鼠无明显影响,无明确的毒性靶器官和敏感指标,恢复期观察也未见延迟性毒性反应,提示本发明的中药制剂临床应用的剂量安全性较高。 Select SD rats for use, give different concentrations (18.0, 6.0, 2.0g crude drug/kg) of the Chinese medicine preparation honeyed pills of the present invention, gavage once a day, for 90 consecutive days, kill 1/2 of each group alive 24 hours after the last administration Animals (half male and half female), and the remaining 1/2 animals continued to be observed for 2 weeks before being killed alive. During the test, the appearance, general behavior, food intake and body weight changes of the animals were observed, and hematology (RBC, HB, reticulocyte, PLT, CT, WBC and classification) and blood biochemistry ( AST, ALT, ALP, Glu, BUN, Crea, TP, T.BIL, ALB, CHOL), urine biochemistry, organ coefficient, histopathology and other indicators inspection. The test results show that: the preparation of the present invention is in high, middle and low dose group animals in good general condition, and there are no abnormal changes in appearance signs, behavioral activities, food intake and body weight growth; Urine biochemical examinations were all within the normal range, and there was no significant difference between the groups; no obvious abnormalities were found in the histopathological examination of major organs in each group. The above indicators did not change after 2 weeks of drug withdrawal. The test dosage is respectively 180, 60, and 20 times of the clinical dosage, and according to the test results, the Chinese medicine preparation of the present invention is administered continuously for 90 days at high, medium and low dosages (18.0, 6.0, 2.0g crude drug/kg). It has no obvious effect on rats, no clear target organs of toxicity and sensitive indicators, and no delayed toxic reaction is observed in the recovery period, suggesting that the dose safety of the clinical application of the traditional Chinese medicine preparation of the present invention is relatively high.
典型病例及疗效 : Typical cases and curative effect:
曾XX,60岁,退休,主诉:间断腰背痛五年于2012年3月门诊治疗,绝经年龄55岁,已绝经五年;体格检查:身高165CM,体重58KG,BMI:21.3kg/m2,骨折外伤:11-10-27因摔倒而导致右尺骨骨折,骨科处理,12-1-9再次摔倒,至左腕骨骨折,骨科处理;今年 3 月 5日去医院检查骨密度 :腰椎 :L1-2.7、L2-2.2、L3-3.1、L4-3.0。患者服用本发明药物两个疗程后,关节疼痛、肿胀减轻,活动功能好转。 Zeng XX, 60 years old, retired, chief complaint: five years of intermittent low back pain, outpatient treatment in March 2012, menopausal age 55 years old, has been menopausal for five years; physical examination: height 165CM, weight 58KG, BMI: 21.3kg/m2, Fracture trauma: On 11-10-27, the right ulna was fractured due to a fall, orthopedic treatment; on 12-1-9, he fell again, and the left wrist was fractured, and orthopedic treatment; on March 5 this year, he went to the hospital for bone density examination: Lumbar spine: L1-2.7, L2-2.2, L3-3.1, L4-3.0. After the patient takes the medicine of the present invention for two courses of treatment, joint pain and swelling are alleviated, and the activity function takes a turn for the better.
实施例5,配方: Embodiment 5, formula:
枇杷芋10g、覆盆子10g、菟丝子15g、栗子5g、枸杞子15g、女贞子0.9g、黄精15g、淫羊藿15g、雪莲花0.8g、巴戟天0.09g、仙茅0.09g、老鹳草0.09g、乌药叶15g、沉香10g、路路通15g、壁虎5g、鳖甲15g、豨莶草0.09g、丹参15g、芝麻10g、一叶萩0.09g、仙灵脾0.09g、马尾千金草10g、心叶荚蒾根10g、双股箭0.09g、桃仁15g、大枣15g、桑寄生5g、桑椹15g、蜂乳15g、冬虫夏草5g、木瓜15g; Loquat taro 10g, raspberry 10g, dodder 15g, chestnut 5g, medlar 15g, privet fruit 0.9g, sealwort 15g, epimedium 15g, snow lotus 0.8g, Morinda officinalis 0.09g, curculigo 0.09g, geranium Grass 0.09g, black medicine leaves 15g, agarwood 10g, passepartout 15g, gecko 5g, turtle shell 15g, scutellaria 0.09g, salvia miltiorrhiza 15g, sesame 10g, hagi 0.09g, fairy spleen 0.09g, horsetail daughter Grass 10g, heart leaf viburnum root 10g, double arrow 0.09g, peach kernel 15g, jujube 15g, mulberry 5g, mulberry 15g, bee milk 15g, cordyceps 5g, papaya 15g;
所述中药组合物的剂型为蜜炼丸剂的制备方法包括: The dosage form of described Chinese medicine composition is that the preparation method of honey refining pill comprises:
步骤a,将除蜂乳外的原料药加入5-10倍量的60-90%乙醇浸泡1-2小时,加热提取1-2小时,去上清液,药糊继续加热浓缩至浸膏状,静置备用,成为组分1。 Step a, add 5-10 times the amount of 60-90% ethanol to the raw materials except bee milk, soak for 1-2 hours, heat and extract for 1-2 hours, remove the supernatant, and continue heating and concentrating the drug paste until it becomes an extract , let it stand for later use, and become component 1.
步骤b,可以将药渣加水浸泡1-2小时,提取两次,每次1-1.5小时,合并提取液, 80-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时 1.36的浸膏,加热浓缩,30分钟~45分钟,提取活性成份,将浓缩液静置成浸膏状,作为组分2。 In step b, soak the dregs in water for 1-2 hours, extract twice, each time for 1-1.5 hours, combine the extracts, filter with 80-120 mesh, and then ultrafilter through an ultrafiltration column with a cut-off molecular weight of 5000-10000 , the ultrafiltrate is concentrated under reduced pressure to the extract with a relative density of 1.36 at 80°C, heated and concentrated for 30 minutes to 45 minutes to extract the active ingredient, and the concentrated solution is left to stand to form an extract, which is used as component 2. the
步骤c,将上述两种浸膏浓缩成糊状,加蜂乳搓成丸剂。 Step c: Concentrate the above two extracts into a paste, add bee milk and knead into a pill. the
长期毒性试验:Long-term toxicity test:
选用SD大鼠,给予不同浓度(18.0、6.0、2.0g生药/kg)的本发明的中药制剂蜜丸剂,每天灌胃一次,连续90天,末次给药后24小时各组活杀1/2动物(雌雄各半),其余1/2动物继续观察2周后活杀。试验期间观察动物的外观、一般行为、摄食量、体重变化,给药后90天和停药2周进行血液学(RBC、HB、网织红细胞、PLT、CT、WBC及分类)和血液生化(AST、ALT、ALP、Glu、BUN、Crea、TP、T.BIL、ALB、CHOL)、尿液生化、脏器系数、病理组织学等指标检查。试验结果表明:本发明制剂在高、中、低剂量组动物一般状态良好,外观体征、行为活动、进食量和体重增长均无异常变化;三个剂量组及对照组血液学检查、血液生化学、尿液生化检查均在正常范围,组间无显著差异;各组主要脏器组织病理学检查未见明显异常。上述指标停药2周后也未见改变。本试验用药剂量分别为临床用药剂量的180、60、20倍,根据试验结果本发明的中药制剂在高、中、低三个剂量(18.0、6.0、2.0g生药/kg)连续90天给药对大鼠无明显影响,无明确的毒性靶器官和敏感指标,恢复期观察也未见延迟性毒性反应,提示本发明的中药制剂临床应用的剂量安全性较高。 Select SD rats for use, give different concentrations (18.0, 6.0, 2.0g crude drug/kg) of the Chinese medicine preparation honeyed pills of the present invention, gavage once a day, for 90 consecutive days, kill 1/2 of each group alive 24 hours after the last administration Animals (half male and half female), and the remaining 1/2 animals continued to be observed for 2 weeks before being killed alive. During the test, the appearance, general behavior, food intake and body weight changes of the animals were observed, and hematology (RBC, HB, reticulocyte, PLT, CT, WBC and classification) and blood biochemistry ( AST, ALT, ALP, Glu, BUN, Crea, TP, T.BIL, ALB, CHOL), urine biochemistry, organ coefficient, histopathology and other indicators inspection. The test results show that: the preparation of the present invention is in high, middle and low dose group animals in good general condition, and there are no abnormal changes in appearance signs, behavioral activities, food intake and body weight growth; Urine biochemical examinations were all within the normal range, and there was no significant difference between the groups; no obvious abnormalities were found in the histopathological examination of major organs in each group. The above indicators did not change after 2 weeks of drug withdrawal. The test dosage is respectively 180, 60, and 20 times of the clinical dosage, and according to the test results, the Chinese medicine preparation of the present invention is administered continuously for 90 days at high, medium and low dosages (18.0, 6.0, 2.0g crude drug/kg). It has no obvious effect on rats, no clear target organs of toxicity and sensitive indicators, and no delayed toxic reaction is observed in the recovery period, suggesting that the dose safety of the clinical application of the traditional Chinese medicine preparation of the present invention is relatively high.
典型病例及疗效 : Typical cases and curative effect:
刘XX,女,年龄 55 岁,因骨质疏松,髋关节退行性变并硬化,走路多了大腿疼痛。患者服用本发明药物两个疗程后,大腿疼痛减轻,活动功能好转。 Liu XX, female, aged 55 years, due to osteoporosis, hip joint degeneration and hardening, thigh pain after walking too much. After the patient took the medicine of the present invention for two courses of treatment, the thigh pain was relieved, and the activity function took a turn for the better.
“肾主骨”、“肾为先天之本”,中年以后,肾精逐渐衰竭,督任二脉损伤,肾亏则髓空,骨不充养而瘦弱。腰为肾之府,故腰痛;筋骨痿弱故无力。肾虚于下,五脏得不到温煦,阳气衰微,阴精不足,故虚热往来,气怯自汗。 "Kidney governs bone", "kidney is the innate foundation", after middle age, the kidney essence gradually fails, the two channels of governor and Ren are damaged, the kidney is deficient, the marrow is empty, the bone is not nourished and becomes thin and weak. The waist is the house of the kidneys, so lumbago; weak muscles and bones, so weakness. When the kidney is deficient, the five internal organs cannot be warmed, the yang energy is weakened, and the yin essence is insufficient, so the deficiency and heat come and go, and the qi is timid and spontaneous sweating. the
依据中医“肾主骨”的理论,《素问-至真要大论》说:“咸先入肾”,长期使用咸味食物就会造成与之相应的内脏机能强盛。通过药膳的使用调动机体潜能,得到防治骨质疏松的目的。其中鳖甲补肾滋阴,治疗腰膝酸软;枸杞子补肾益精。佐以大枣、丹参养血补气,药膳食营养共奏益肾壮骨之功效。 中医的肾包括了西医的泌尿生殖系统、内分泌系统及神经系统的功能,作为一组功能单位。肾虚证是以下丘脑垂体多个靶源系统功能紊乱、全身生理机能减退为特征的一种机体反应状态,肾虚可影响到磷钙代谢,反映在骨矿物质代谢方面就出现了骨密度的下降。中药主要补肝脾肾,作为具有“多成分、多靶点、协同促进增效、配伍适中安全”特征的补肾中药(草药)复方,开展了大量基础实验和临床应用研究,取得了令人瞩目的成就。 肾虚是骨质疏松本,补肾法可以纠正机体免疫系统的功能低下,恢复下丘脑—垂体—靶腺器官的功能活动,促进骨钙沉积,抑制骨吸收,加快骨形成,延缓骨量丢失,升高骨矿含量和骨密度,达到治疗骨质疏松症的目的。 According to the theory of "kidney governing bone" in traditional Chinese medicine, "Suwen-Zhizhenyaodalun" says: "Salt enters the kidney first", and long-term use of salty food will cause the corresponding visceral function to be strong. The purpose of preventing and treating osteoporosis can be obtained by mobilizing the potential of the body through the use of medicated diet. Among them, soft-shelled turtle tonifies kidney and nourishes yin, treats weakness of waist and knees; fruit of wolfberry tonifies kidney and nourishes essence. Accompanied by jujube and red sage root to nourish blood and nourish qi, medicine and dietary nutrition have the effect of nourishing kidney and strengthening bones. The kidney in Chinese medicine includes the functions of the genitourinary system, endocrine system and nervous system in Western medicine, as a group of functional units. Kidney deficiency syndrome is a body reaction state characterized by dysfunction of multiple target source systems of the hypothalamus and pituitary gland and hypophysiological dysfunction of the whole body. Kidney deficiency can affect the metabolism of phosphorus and calcium, which is reflected in the bone mineral metabolism. Traditional Chinese medicine mainly nourishes the liver, spleen and kidney. As a kidney-tonifying traditional Chinese medicine (herbal medicine) compound with the characteristics of "multi-components, multi-targets, synergistic promotion and synergy, and moderate compatibility and safety", a large number of basic experiments and clinical application research have been carried out, and remarkable achievements have been made. achievement. Kidney deficiency is the root cause of osteoporosis. Tonifying the kidney can correct the low function of the body's immune system, restore the functional activities of the hypothalamus-pituitary-target gland organs, promote bone calcium deposition, inhibit bone resorption, accelerate bone formation, delay bone loss, and increase bone loss. High bone mineral content and bone density, to achieve the purpose of treating osteoporosis. the
临床表现: Clinical manifestations:
1、骨全身痛,以脊柱与骨盆及骨折处为主,当改变体位或上、下楼梯时更甚。 1. General pain in the bones, mainly in the spine, pelvis and fractures, which is worse when changing body positions or going up and down stairs.
2、身材变矮。 2. Short stature. the
3、易骨折。 3. Easy to fracture. the
本发明试验研究: Experimental research of the present invention:
1 对象与方法 1.1 对象 2012年1月至2013年6月在接诊的绝经期骨质疏松症妇女200例。 1 Objects and methods 1.1 Objects 200 cases of menopausal osteoporosis women received from January 2012 to June 2013.
入选标准:①女性 ②年龄在55岁到65岁 ③绝经期骨质疏松症 ④骨密度异常 ⑤ALP异常。 Inclusion criteria: ① Female ② Age between 55 and 65 years old ③ Menopausal osteoporosis ④ Abnormal bone mineral density ⑤ Abnormal ALP. the
排除标准:①男性 ②年龄小于55岁大于65岁 ③诊断不明确 ④骨密度或ALP无异常 ⑤过敏体质或对试验用药过敏者 ⑥怀疑或确有酒精、药物滥用病史者 ⑦3个月内参加过其它临床试验者 ⑧研究者认为应该排除的。 1.2 方法 1.2.1纳入标准 ①绝经期妇女(年龄在55岁到65岁)。②患者纳入诊断按国际标准, 即双能X 线吸收法测量腰椎骨密度低于正常青年女性平均值的2. 5 个标准差( 骨密度< 0. 861 g / cm2) , 即可诊断为骨质疏松。 1.2.2排除标准 无内分泌代谢或其它影响钙磷代谢的慢性疾病, 亦无肝肾疾病史和服用影响钙磷代谢的药物史 1.2.3本研究以使用本发明中药组合物配方,不采用抗骨质疏松基础疗法,通过与患者协商,征得患者同意后,签署知情同意书并密切合作。 1.2.4 120例住院的绝经期骨质疏松症妇女,用本发明中药组合物前测定定量计算机层面扫描法( QCT) 测腰椎松质骨密度、双能X 线吸收法( DEXA) 测腰椎( L2-L4) 和股骨颈( Neck) 骨密度及ALP测定。 1.2.5 通过临床治疗的同时,服用本发明中药,每服药分3剂,3剂/日,15天为一个疗程,服用1月后相同方法测定骨密度、ALP。 1.2.6采用SPSS13.0统计学软件进行数据分析骨密度、ALP。 1.3 观察指标 两组患者分别于服用药前、服用药1月后,测定定量计算机层面扫描法( QCT) 测腰椎松质骨密度、双能X 线吸收法( DEXA) 测腰椎( L2-L4) 和股骨颈( Neck) 骨密度及ALP测定。 1.4 统计学分析 采用SPSS13.0统计学软件,进行数据分析骨密度、ALP。 2 结果 2.1 一般情况 服用药前,各组患者测定定量计算机层面扫描法( QCT) 测腰椎松质骨密度、双能X 线吸收法( DEXA) 测腰椎( L2-L4) 和股骨颈( Neck) 骨密度及ALP测定。无统计学意义。 2.2 骨密度、ALP指标变化情况 服用药1月后,各组患者分别测定定量计算机层面扫描法( QCT) 测腰椎松质骨密度、双能X 线吸收法( DEXA) 测腰椎( L2-L4) 和股骨颈( Neck) 骨密度及ALP测定。 2.3短期临床结局 对照组100例患者骨痛无明显改善,功能障碍无明显改善;服用药组100例患者1月后分别有骨痛明显改善,功能障碍恢复正常。 Exclusion criteria: ①Male ②Age younger than 55 and older than 65 ③Unclear diagnosis ④No abnormality in bone mineral density or ALP ⑤Allergic constitution or allergic to experimental drugs ⑥Suspected or confirmed history of alcohol and drug abuse ⑦Participated within 3 months Other clinical trialists ⑧ researchers think should be excluded. 1.2 Methods 1.2.1 Inclusion criteria ① Menopausal women (aged 55 to 65 years old). ②Patients were included in the diagnosis according to international standards, that is, if the bone mineral density of the lumbar spine measured by dual-energy X-ray absorptiometry is lower than 2.5 standard deviations of the average value of normal young females (bone density < 0.861 g/cm2), the diagnosis of osteoporosis can be made. quality loose. 1.2.2 Exclusion criteria No endocrine metabolism or other chronic diseases affecting calcium and phosphorus metabolism, no history of liver and kidney diseases and taking drugs that affect calcium and phosphorus metabolism Basic osteoporosis therapy, through consultation with the patient, after obtaining the consent of the patient, sign the informed consent and cooperate closely. 1.2.4 120 hospitalized menopausal women with osteoporosis, measured the lumbar cancellous bone density by quantitative computerized tomography (QCT) and measured the lumbar spine by dual-energy X-ray absorptiometry (DEXA) before the Chinese medicine composition of the present invention L2-L4) and femoral neck (Neck) bone mineral density and ALP determination. 1.2.5 While undergoing clinical treatment, take the traditional Chinese medicine of the present invention, each dose is divided into 3 doses, 3 doses/day, 15 days is a course of treatment, and the same method is used to measure bone density and ALP after taking it for 1 month. 1.2.6 SPSS13.0 statistical software was used for data analysis of bone density and ALP. 1.3 Observation indicators Before taking the medicine and after taking the medicine for 1 month, the patients in the two groups were measured by quantitative computed tomography (QCT) to measure the lumbar cancellous bone density, and by dual energy X-ray absorptiometry (DEXA) to measure the lumbar spine (L2-L4). And femoral neck (Neck) bone mineral density and ALP determination. 1.4 Statistical analysis SPSS13.0 statistical software was used for data analysis of bone density and ALP. 2 Results 2.1 General situation Before taking the medicine, quantitative computed tomography (QCT) was used to measure lumbar cancellous bone mineral density, and dual energy X-ray absorptiometry (DEXA) was used to measure lumbar spine (L2-L4) and femoral neck (Neck). Bone density and ALP determination. Not statistically significant. 2.2 Changes in bone mineral density and ALP indexes After taking the medicine for one month, the patients in each group were measured by quantitative computed tomography (QCT) to measure the lumbar cancellous bone density, and by dual energy X-ray absorptiometry (DEXA) to measure the lumbar spine (L2-L4). And femoral neck (Neck) bone mineral density and ALP determination. 2.3 Short-term clinical outcome The 100 patients in the control group had no significant improvement in bone pain and dysfunction; the 100 patients in the medication group had significant improvement in bone pain and functional impairment returned to normal after one month. the
疗效评定标准 Curative effect evaluation standard
1、治愈 :消失,活动功能恢复正常,实验室检查正常。 1. Cure: disappear, activity function returns to normal, laboratory examination is normal.
2、好转 :关节疼痛、肿胀减轻,活动功能好转。 2. Improvement: joint pain and swelling are relieved, and the activity function is improved. the
3、未愈 :关节疼痛及肿胀无变化。 3. Unhealed: no change in joint pain and swelling. the
服药组治疗结果统计: The statistics of the treatment results of the medication group:
治愈率78%,好转率19%,未愈率3% The cure rate is 78%, the improvement rate is 19%, and the non-healing rate is 3%.
其中 :总有效率 = 治愈率 + 好转率 Among them: total effective rate = cure rate + improvement rate
总有效率为97% The total effective rate is 97%
故本发明一种治疗绝经妇女骨质疏松症的中药组合物有效。 Therefore, a Chinese medicinal composition for treating postmenopausal women's osteoporosis is effective.
the
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310299562.6A CN103330837B (en) | 2013-07-17 | 2013-07-17 | A traditional Chinese medicine composition for treating postmenopausal women's osteoporosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310299562.6A CN103330837B (en) | 2013-07-17 | 2013-07-17 | A traditional Chinese medicine composition for treating postmenopausal women's osteoporosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103330837A true CN103330837A (en) | 2013-10-02 |
| CN103330837B CN103330837B (en) | 2014-11-19 |
Family
ID=49239087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310299562.6A Expired - Fee Related CN103330837B (en) | 2013-07-17 | 2013-07-17 | A traditional Chinese medicine composition for treating postmenopausal women's osteoporosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103330837B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103860905A (en) * | 2014-03-14 | 2014-06-18 | 李群 | Traditional Chinese medicine preparation for treating osteoporosis |
| CN103877140A (en) * | 2014-04-04 | 2014-06-25 | 大连普瑞康生物技术有限公司 | Application of saussurea involucrate culture in preparation of product for promoting bone health |
| KR101809151B1 (en) | 2013-07-18 | 2017-12-15 | (주)앗코스텍 | Composition for prevention, improvement or treatment of osteoporosis comprising kirenol or extract of Sigesbeckia spp. |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1313111A (en) * | 2000-03-15 | 2001-09-19 | 蒲荣 | Health-care medical wine for invigorating function of kidney and strengthening bone |
| CN1899479A (en) * | 2006-07-05 | 2007-01-24 | 王悦 | Chinese medicine compound preparation for treating osteoporosis after menopause and its preparation |
-
2013
- 2013-07-17 CN CN201310299562.6A patent/CN103330837B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1313111A (en) * | 2000-03-15 | 2001-09-19 | 蒲荣 | Health-care medical wine for invigorating function of kidney and strengthening bone |
| CN1899479A (en) * | 2006-07-05 | 2007-01-24 | 王悦 | Chinese medicine compound preparation for treating osteoporosis after menopause and its preparation |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101809151B1 (en) | 2013-07-18 | 2017-12-15 | (주)앗코스텍 | Composition for prevention, improvement or treatment of osteoporosis comprising kirenol or extract of Sigesbeckia spp. |
| CN103860905A (en) * | 2014-03-14 | 2014-06-18 | 李群 | Traditional Chinese medicine preparation for treating osteoporosis |
| CN103877140A (en) * | 2014-04-04 | 2014-06-25 | 大连普瑞康生物技术有限公司 | Application of saussurea involucrate culture in preparation of product for promoting bone health |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103330837B (en) | 2014-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103349753B (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
| CN101417086B (en) | Traditional Chinese medicine preparation for treating myocardial ischemia | |
| CN101066303B (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation | |
| CN104288644A (en) | A kind of pharmaceutical composition for treating spleen deficiency and its preparation method | |
| CN104922543A (en) | Medicine composite for treating amenorrhea and preparation method thereof | |
| CN101011544A (en) | Gout rapid recovery pill(capsule) and preparation technique thereof | |
| CN103330837B (en) | A traditional Chinese medicine composition for treating postmenopausal women's osteoporosis | |
| CN101239151B (en) | Chinese medicine for preventing and controlling cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN104645249B (en) | One kind treats treating coronary heart disease and angina pectoris | |
| CN102657795A (en) | Traditional Chinese medicine preparation for promoting postoperative incision healing | |
| CN103550548B (en) | A kind of Chinese medicine composition for the treatment of constipation | |
| CN102488781A (en) | Traditional Chinese medicine composition for treating wind-damp-cold arthralgia | |
| CN105362682A (en) | External-use medicine for treating hypomenorrhea | |
| CN100502925C (en) | Lipid-lowering and liver-protecting drug and processing method thereof | |
| CN105616704A (en) | Traditional Chinese medicine preparation for sclerotin healing of osteoporotic fracture | |
| CN105213905A (en) | A kind of Chinese medicine composition and application thereof preventing and treating postmenopausal osteoporosis | |
| CN104888132A (en) | Traditional Chinese medicine composition for treatment of chronic gastritis | |
| CN104826095B (en) | A kind of chondroitin co-production protein powder and its production method and application | |
| CN104840891A (en) | Traditional Chinese medicine preparation used for treating alcoholic cardiomyopathy and preparation method thereof | |
| CN105343298B (en) | Navel patch for treating chronic constipation and preparation method thereof | |
| CN104800836B (en) | A kind of Isin glue collagen and its production method and application | |
| CN109876127A (en) | A kind of blood-nourishing angelica capsules and preparation method thereof | |
| CN100571739C (en) | Compound traditional Chinese medicine for treating cardiovascular disease and preparation method thereof | |
| CN109078157A (en) | A kind of anti-tumor drug and preparation method thereof | |
| CN105327024A (en) | Traditional Chinese medicine preparation for treating rheumatoid arthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: SHANDONG QILU HOSPITAL Free format text: FORMER OWNER: WANG LEI Effective date: 20141013 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Lei Inventor after: Zhang Mei Inventor after: Liu Haichun Inventor after: Wang Xia Inventor before: Wang Lei Inventor before: Liu Haichun Inventor before: Wang Xia |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG LEI LIU HAICHUN WANG XIA TO: WANG LEI ZHANG MEI LIU HAICHUN WANG XIA |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20141013 Address after: 250012 Shandong, Lixia District, Ji'nan Province Cultural Road West, No. 107 Applicant after: Shandong Qilu Hospital Address before: 250012 Shandong, Lixia District, Ji'nan Province Cultural Road West, No. 107 Applicant before: Wang Lei |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141119 Termination date: 20150717 |
|
| EXPY | Termination of patent right or utility model |